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CarbMetSim is a discrete event simulator that tracks the changes of blood glucose
level of a human subject after a timed series of diet and exercises activities. CarbMetSim
implements wider aspects of carbohydrate metabolism in individuals to capture the average
effect of various diet/exercise routines on the blood glucose level of diabetic patients. The
simulator is implemented in an object-oriented paradigm, where key organs are represented
as classes in the CarbMetSim. Key organs (stomach, intestine, portal vein, liver, kidney,
muscles, adipose tissue, brain and heart) are implemented to the extent necessary to simulate
their impact on the production and consumption of glucose. Metabolic pathways (glucose
oxidation, glycolysis and gluconeogenesis) have been taken in account in the operation of
various organs. In accordance with published research, the impact of insulin and insulin
resistance on the operation of various organs/pathways is captured. CarbMetSim offers
broad versatility to configure the insulin production ability, the average flux along various
metabolic pathways and the impact of insulin resistance on different aspects of carbohydrate
metabolism. However, the CarbMetSim project has not yet been finished. There are many
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aspects and metabolic pathways that have not been implemented or have been implemented
in a simple manner. Also, additional validation is required before the simulator can be
considered ready for use by people with Diabetes.
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Diabetes mellitus, also called diabetes, is a group of diseases that affect how the human
body regulates the blood sugar (glucose) level and is mainly related to abnormally high
glucose levels in the blood. Understanding the role of one of the key hormones (insulin)
in the human body that regulates blood glucose will help us understand the underlying
causes for developing the disease. In general, the human body uses food to produce the
energy needed for daily activities and cells’ chemical reactions. The energy is formed by
breaking down the consumed food or drink into simple sugar forms called glucose. Glucose
is transported through the bloodstream to the body’s cells by the insulin hormone to be
utilized as a fuel source for different cell’s chemical reactions and metabolism processes.
The insulin hormone is produced by the beta cells in the pancreas, and it is the primary
transporter of glucose to the body’s cells. It binds to the insulin receptors on the body’s cells,
signaling them to absorb glucose from the bloodstream. Usually low insulin levels circulate
constantly throughout the body when the Blood Glucose Level (BGL) is low. However, when
the BGL increases due to meal ingestion, for example, insulin levels spike to return BGL
to the normal level and restore the body to the normoglycemia status (the presence of a
normal concentration of BGL). Besides, insulin signals the liver to absorb glucose and store
it as glycogen in the liver’s cells. If the amount of glycogen exceeds the limit, glucose will be
converted into fatty acids, transferred to other parts of the body, and stored as fat in tissues.
On the other hand, the Glucagon hormone produced by the alpha cells in the pancreas
regulates BGL when it is low by signaling the liver to convert the stored glycogen back to
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glucose, which in turn will raise BGL and return the body status to the normoglycemia.
Knowing the basic relationship between the insulin hormone and BGL helps us to cite
formal definitions of the disease here. In this literature, I am referencing two definitions of
the disease that have been stated by two prestigious diabetes research institutes in the USA.
The American Diabetes Association [6] defines Diabetes as “ a group of metabolic diseases
characterized by hyperglycemia (high BGL) resulting from defects in insulin secretion, insulin
action or both ”. Moreover, the Diabetes Research Institute foundation [36] states that it is
a serious condition that occurs when the body cannot make or effectively use its own insulin.
Diabetic people are classified into two different types[36][34][6]: type I and type II. In the
type I group, the pancreas cannot produce insulin at all, or it just produces very little of it.
This occurs because the beta cells of the pancreas are attacked and damaged by the immune
system. Type I diabetic patients are insulin dependent, and they must take insulin dosages
as part of their treatment. Insulin dosages can be taken by injection with a needle or with an
insulin pump. People with type I usually develop the disease at a young age. Therefore, it is
less common than the other type (type II), and accounts for only 5–10%[34]of those who have
diabetes. On the other hand, in the type II diabetes group, the body’s cells resist insulin
signals and do not absorb glucose from the bloodstream (can’t effectively use it). Also, in
some cases the pancreas cannot produce sufficient amounts of the insulin hormone. Usually
type II diabetes is developed due to lifestyle issues, such as obesity and lack of exercises.
Treatments require following healthy lifestyle changes, taking medications if needed, and
others. Diabetes type II can be developed due to genetic issues as well. It is the most
common type, and it accounts for 90–95% [34] of those who have diabetes.
The World Health Organization (WHO) published a global study [84] reporting that
the number of diabetic patients worldwide has increased from 108 million in 1980 to 422
million in 2014. Also, [21] noted that the commonness of the disease among adults over
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18 years old has risen from 4.7% in 1980 to 8.5% in 2014. Unfortunately, the data also
shows that around two-thirds of all diabetes cases occur in middle and low-income countries
[6]. On the other hand, in the U.S there are 30.3 million people who have diabetes (9.4%
of the U.S. population)[82][33], this includes adults aged 18 years or older and people who
were not aware of it or did not report having diabetes (7.2 million or 23.8% of people with
diabetes)[33]. The global financial cost of diabetes is significant and will increase by 2030 [14].
The annual cost of diabetes (including the cost of treatment) was calculated in international
dollars by [117], and it was estimated at 825 billion dollars per year, with the highest cost
to individual countries being in China ($170 billion), the USA ($105 billion), and India ($73
billion). These calculations do not include workdays lost due to the disease, which would
significantly increase the costs if incorporated, as the author claimed.
A diabetic patient may develop serious health complications if his\her BGL is not con-
trolled appropriately. These health complications are specific and varied. The level of the
complications and difficulties depends on the patient’s lifestyle and his\her awareness of
diabetes-associated health issues. In general, the following health problems may occur for
a diabetic patient who does not follow a healthy lifestyle or control his\her BGL: neuropa-
thy, nephropathy, retinopathy, cardiovascular disease, stroke, and Peripheral Artery Disease
(PAD)[86]. Moreover, diabetic patients with uncontrolled BGL may develop hyperglycemia
(high BGL) that causes chronic damage such as retinopathy and kidney failure [105]. Also,
diabetic patients (specifically type I) may suffer hypoglycemia episodes. The hypoglycemia
episode happens when BGL is much lower than the normal levels. It usually occurs as a side
effect of the blood glucose lowering medications. Hypoglycemia may lead to brain damage,
coma, and, eventually, death [105][104].
To avoid these health complications, the patient needs to regularly see his\her endocri-
nologist, take medicines (if required), and control non-clinical parameters that significantly
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affect and help maintain healthy BGL (glycemic control). Firm glycemic control is widely
proven in preventing or reducing many diabetes health complications.[80][41][42] [95][109][65].
For instance, muscles absorb glucose from the blood when the human body is engaged in
physical exercises, even in the absence of insulin. These exercises may cause hypoglycemia if
it is not carefully coordinated with food and medication intake. Following a healthy lifestyle
that includes a healthy diet and exercising regularly must be coordinated with daily BGL
monitoring to help maintain BGL as close as possible to the normal ranges over time.
To observe BGL daily, Continuous Glucose Monitoring (CGM) portable sensors [62] have
been developed. These devices help the diabetic patient track his\her BGL continuously and
automatically throughout the day. These devices can help control BGL. But either they are
expensive or they are not easily available to a large population of diabetic patients world-
wide. Diabetic patients will benefit from having an available and free tool that will help
them decide how they should plan their food and exercise activities to keep their BGL
under control. Indeed, they need help in realizing the impact of a particular sequence of
food and exercise activities on their BGL. One solution is to build a simulation tool that
reasonably predicts the impact of diet and exercise activities on patient’s BGL using the vast
knowledge of energy metabolism in human beings. A few similar simulators exist [64][72]
but are designed toward predicting the impact of individual meals and are not available in
a manner that can be freely used by individuals.
In this thesis, a CarbMetSim [48] (the Carbohydrate Metabolism Simulator) is de-
scribed. CarbMetSim is an open-source [47] simulation software that predicts minute by
minute BGL in response to an arbitrary length sequence of food and exercise activities. The
proposed simulator is freely available and it is based on discrete event model, in contrast to
existing simulation tools that are classifed as continuous time models that use differential
and algebraic equations to describe physiological detail. In CarbMetSim, the time increments
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in ticks, where each tick is one minute long. At the start of each tick, CarbMetSim fires the
food/exercise events that need to be fired at the time and involves various simulated body
organs to perform the work that is supposed to be happening during this tick.
CarbMetSim implements wider aspects of carbohydrate metabolism in individuals to
capture the average effect of various diet/exercise routines on the BGL of diabetic patients.
The simulator implements the following key organs: stomach, intestine, portal vein, liver,
kidney, muscles, adipose tissue, brain and heart. The organs have been implemented to the
extent necessary to simulate their impact on the production and consumption of glucose.
Moreover, the following metabolic pathways have been taken in account in CarbMetSim:
glucose oxidation, glycolysis and gluconeogenesis. These pathways are simulated in the op-
eration of various organs. In accordance with published research, the impact of insulin and
insulin resistance on the operation of various organs/pathways is captured. CarbMetSim
offers broad versatility to configure the insulin production ability, the average flux along
various metabolic pathways and the impact of insulin resistance on different aspects of car-
bohydrate metabolism. Thus the simulator can be customized to a given individual by using
appropriate values to various configurable parameters.
However, the CarbMetSim project has not yet been finished. There are many aspects
and metabolic pathways that have not been implemented or have been implemented in
a simple manner. For instance, the protein and lipid metabolism are implemented in a
simplified manner. CarbMetSim doesn’t take the monosaccharides (other than glucose) into
consideration and assumes that after digestion all the dietary carbohydrates become glucose.
Moreover, the impact of insulin is captured in a simplified manner and does not model other
important hormones such as glucagon. The impact of short-term externally injected insulin
is not yet modeled, and it is currently possible to simulate just aerobic exercise. Finally, the
simulator cannot yet translate a user’s diet/exercise/BGL data into the values of simulation
5
parameters governing the behavior of different organs.
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Chapter 2
Modeling carbohydrate metabolism in humans—A
literature review
Oviedo’s paper [85] provides a dense review of most of the significant BGL prediction
models and the models that predict hypo\hyperglycemia episodes for type I diabetic patients.
The paper only covered the models that have been published between 2010 and spring 2016,
due to the massive numbers of the published models in the glycemic control. BGL prediction
models were classified into four different groups: physiological models group, data-driven
models group, hybrid models group, and control-oriented prediction models group.
Physiological models are mathematical models that simulate all or some of the physiolog-
ical processes of glucose consumptions (glucose metabolism) and the corresponding insulin
actions that depend entirely on the current levels of glucose in the blood stream. Generally,
these models consist of compartmental sub-models such as an insulin absorption sub-model
and a carbohydrate digestion sub-model that simulate all the events that directly affect BGL.
The common inputs for these sub-models are carbohydrate intake, insulin therapy, physical
activities, and stress. Building these models requires a solid physiological knowledge of all
the related processes of glucose metabolic process. This knowledge is needed to simulate
these metabolic processes and to identify all the physiological parameters that are required
to describe the model accurately. Consequently, physiological models are classified based
on the complexity into two main subgroups: minimal and maximal models. The minimal
models simulate the vital physiological processes of glucose metabolism and insulin action
by using limited number of mathematical equations and parameters. On the other hand,
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the maximal models or the comprehensive models use the available knowledge to simulate
all the physiological processes of the glucose metabolism and insulin action by using a full
and complex set of equations and parameters. The Dall Man Model [24] , The Hovirka [51],
and Bergman minimal model [10] are the most popular used physiological models for BGL
predictions.
Data-driven models are less complicated than physiological models. These do not sim-
ulate the physiological processes of glucose metabolism, but they employ different artificial
techniques on the collected patient’s daily activities to predict future BGL level. The main
goal of these models is to simulate how food intake, exercises, and insulin therapy affect BGL.
However, simple mathematical equations are used to identify a few parameters to simulate
the glucose kinetics and insulin action. There is no single dominantly used artificial method
in this group due to the massive number of existing machine learning techniques and the
ability of mixing these techniques to achieve more accurate predictions.
Hybrid models combine the physiological models and the data-driven models in predicting
BGL and hypo\hyperglycemic episodes. The physiological models used here usually are the
meal models and insulin models. The Dalla Man meal model, the Lehmann model, and the
Deutsch model [68] are the most popular models used to model meal and glucose absorption.
However, Berger’s model and the Dalla Man model are the most used models in considering
insulin as an input. Data-driven models are used to draw the relationship between the user’s
activities and the outputs (future BGL). User activities are the carbohydrates intake and
insulin dosage. All the surveyed models in this group used carbohydrate as a main input,
while 78.5% of the surveyed papers use insulin as a secondary input [85].
The control oriented prediction models group includes all the models that are imple-
mented in controllers such as Artificial Pancreases (AP) and belong to one of the previous
groups. The majority of these models belong to the data-driven group, while the few others
8
belong to the physiological group and the hybrid group.
2.1 Knowledge-driven Models
The physiological models or the knowledge-driven models are mathematical models that
are based on human physiology. Indeed, these models are a set of differential and algebraic
equations, and they represent different factors as different compartmental models that affect
each other [19]. For instance, the models in [13][2][40] are linear models that replicate the
BGL and the insulin level in the blood, and they show that the rate of their presence and
absence were linearly proportional to their corresponding levels in the blood. On the other
hand, [18] proposed a non-linear model that considered additional hormones besides insulin
hormone as glucagon. Moreover, [35] proposed a model that composed six compartment
model, one each for BGL, liver glycogen, muscle glycogen, plasma insulin, plasma glucagon
and free fatty acids in plasma. The addition or removal from each compartment occurred
in a non-linear fashion. Other distinguished non-linear multi-compartment models were the
models developed by [17], [55],[22], and [20]. The models are more complex and cover many
physiological details. An overview of the several knowledge-based models are presented in
[103]. This section covers some of the later models.
Bergman et al. introduced a model [10][11] that quantifies the sensitiviy of an individual’s
beta cells to the his\her BGL and the sensitivity of the individual’s BGL to the insulin level
in his\her bloodstream. The proposed model was a minimally complex mathematical model
that is able to capture the individual differences in the two sensitivities mentioned above.
However, the model has been modified by Furler et al [38]. Furler et al. allowed for the
absence of insulin production by the pancreas and external insulin infusion. Moreover,
Bergman et al.’s model has been extended by [98] to include the level of free fatty acids
in plasma. Also it has been extended in [99][25] to include the impact of physical exercise.
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Finally, Bergman et al.’s model was used to study the closed and semi-closed loop optimal
control algorithms to define the insulin infusion profile for an individual [83][32].
In [107], multi-compartment model for glucose circulation was proposed and developed,
where each related organ was modeled as a separate compartment. Another multi-compartment
model was introduced by Guyton et al. [49]. The model consists of:
1. A glucose circulation subsystem. Separate compartments were developed for liver glu-
cose, liver glycogen, kidney glucose, brain tissue glucose, brain blood glucose, peripheral
blood glucose (muscles, adipose tissue), peripheral tissue glucose, central blood glucose
(i.e. gastrointestinal tract), and central tissue glucose.
2. Insulin circulation subsystem. Separate compartments were developed for liver insulin,
which represents insulin from pancreatic beta cells, kidney insulin, peripheral blood
insulin, peripheral tissue insulin, central blood insulin and central tissue insulin.
There are 32 non-linear ordinary differential equations (ODEs) with 11 non-linear ODEs
in the model just to simulate the insulin secretion from the pancreas[103]. Another physio-
logically complex multi-compartment model was proposed by Sorensen [103] that includes a
simplified model for pancreatic insulin secretion. The multi-compartment model made up of
22 non-linear ODEs, of which 11 ODEs were associated with glucose circulation, 10 ODEs
with insulin, and 1 ODE with glucagon. The Guyton/Sorensen models were updated by
Parker et al. [87] [88]. The updated versions consider the uncertainty in parameter values
and include a sub-model for gastric emptying of carbohydrates in a meal [68]. In [51], Hov-
orka et al. developed a multi compartment model of glucose and insulin kinetics. The model
is part of another predictive controller model for sub-cutaneous insulin infusion for people
with type I diabetes. The model consists of:
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1. Two compartment glucose subsystems (modeling glucose absorption, distribution and
disposal).
2. Two-compartment insulin subsystems (modeling insulin absorption, distribution and
disposal).
3. Insulin action subsystem (modeling insulin action on glucose transport, disposal and
endogeneous production).
Dalla Man et al., in their study [24], developed a model that binds the concentrations of
glucose and insulin plasma to different glucose and insulin rates. These rates are:
1. The rate of arrival of glucose from the gastro-intestinal tract.
2. The rate at which the glucose is produced by liver and kidney organs.
3. The insulin dependent and independent rates of glucose usage.
4. The rate of renal extraction of glucose.
5. The rate of insulin secretion by beta cells.
6. The rate of insulin degradation.
The study collected the data from 204 normal and 14 type II diabetic subjects. These
experiment data determined the values of the model parameters. The model was used
to simulate patient behavior in UVA/PADOVA Type I Diabetes Simulator [64] in order to
examine the closed control strategies for insulin pumps. [72] modified the Dalla Man’s model
by combining glucagon secretion/action/kinetics and non-linear increase in insulin-dependent
glucose utilization as BGL declines below the normal range. The new modifications were
implemented in a new version of the UVA/PADOVA simulator.
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Our CarbMetSim simulator is a physiologically complex model like the models presented
by Tiran et al. [107], Guyton et al. [49], Sorensen [103] and Dalla Man [24]. The main
difference is that CarbMetSim uses software to implement the physiological details of various
body organs, and these details are implemented as objects whereas the existing models used
ODEs to model physiological details. Implementing physiological details in software allows
for more complex behavior to be considered and implemented than what is possible using
ODEs. Furthermore, it is easier to modify physiological behavior implemented in software
than via ODEs. Therefore, the presented simulator is an improvement over existing ODE-
based approaches. It is hoped that these benefits coupled with its open-source nature will
allow CarbMetSim to emerge as a popular simulation model of human metabolism for both
diabetes research and self-management tools for diabetic people.
2.2 Data-driven Models
In this section, several significant data-driven models for predicting BGL are covered.
These models were proposed either for diabetic patients type I and\or type II. Data-driven
models are black box models that aim to find the relationship between the inputs and the
outputs of a certain system. In the art of predicting BGL in diabetes, they extract the
information hidden in the patients’ data in order to model the glucose response to various
events, without explicit knowledge of the process behavior of the glucose-insulin regulatory
system. The complexity of the data-driven models determines the desired observed inputs.
Usually the inputs are the recently recorded BGL values, food intake components (such
as carbohydrates, fats, and proteins), exercises, stress, insulin dosages and time of insulin
injections. Moreover, the density of the collected BGL readings play a main role in deter-
mining the accuracy of the predictions. Data-driven models are easier to be designed and
developed in comparison to the physiological models. However, the models cannot provide
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any explanation of how the predicted values are obtained. In general, data-driven models
are classified in two families: Machine Learning Models and Time-Series Models [41]. Ma-
chine learning methods are mathematical descriptions of real-world processes that include
methods of data analysis to automate analytical model building. Different machine-learning
approaches have been used to model the relationship between recent past BGL values and
patient activities with the future BGL. These approaches include rule-based models, multi-
model approaches, Gaussian mixture models (GMM), vector machines for regression (SVR),
reinforcement learning, random support vector models, and artificial NN (ANN) models,
among others. On the other hand, time series analysis predicts future events based on recent
events that have been gathered and spotted at regular time intervals. It comprises meth-
ods to extract meaningful patterns of the collected data that aid in designing an accurate
prediction model.
The Velletta et al. model [109] is an example of using a black box model to predict
future BGL based only on the patient’s activities. The research work used a Gaussian
process and other existing models to model the relationship between the patient’s activities
and their BGL, minute by minute. Patients’ exercises and BGL values were monitored
continuously. Patients were instructed to wear the exercise monitoring device and the CGMS
for approximately two weeks. The CGMS needs to be replaced every three days. Several
existing models have been used to generate part of the required parameters for the Gaussian
process. For instance, the generic insulin model [106] and the popular Lehmann’s food model
[68] have been used to generate the insulin and the carbohydrate parameters, respectively.
The CGMS generated the related glucose parameters, and the exercise monitoring system
extracted the following parameters from the collected physical activity data: the METs
(Metabolic Equivalent) in (kcal/kg/hr),which is the amount of calories that the body burns
to keep itself functioning, Heat flux in (W/m2), and skin temperature in Celsius. Then,
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a Gaussian process [92] was used to return a non-parametric probabilistic model, where
the mean and covariance functions report all knowledge about the modeling process. The
inputs of the model are: glucose, carbohydrate intake, insulin, METs, Heat flux, and skin
temperature. The results indicated that the model can predict BGL in the long term, but
the predicted values were higher than the measured ones. However, it was able to track the
decreases and increases in BGL in the observed period. There are two limitations of the
proposed model: the model considers the carbohydrate as the only source of glucose for the
human body. However, fat and protein also are sources of glucose as well, which the model
does not consider in the modeling process. The model does not consider other parameters
that may affect the insulin absorption, such as the amount of the dose, the site of application,
and exercises.
Similar to Rollins et al.’s model [95] and Velletta et al.’s model [109], Georga et al.
prposed a model [41] that uses a multi-parametric set of free-living data to predict BGL
for type I diabetic patients. The model comprised three white box compartmental models
that mimic the glucose–insulin regulatory system and a fourth black box model that predicts
BGL. The compartmental sub-models are the meal model, the insulin model, and the physical
exercise model. They measure the effects of food intake, exercises, and medications on BGL,
respectively. Indeed, they are used to simulate the related physiological processes to produce
the needed parameters, which will be used later as inputs for the prediction model. Modeling
the effects of the physical exercises on BGL was developed using two different approaches.
The first approach represents the physical exercise input to the prediction model as a set of
the collected data (Metabolic Equivalent of Task (MET), the heat flux (hf), and the skin
temperature (st) variables) that was gathered from the exercise sensor armband. The second
approach represents the physical exercise input as a set of the generated outputs (glucose
concentration and insulin concentration) of the exercise sub-model.
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The compartmental models are represented and influenced by other existing sub-models.
Specifically, the insulin sub-model is a combination of Tarin et al.’s model [106] and Cobelli
et al.’s model [20], with some assumptions and modifications that were made by the authors.
The insulin sub-model simulates the absorption and the pharmacokinetics\pharmacodynamics
of subcutaneously injected insulin as it is described in [106]. It uses [20] model to estimate
plasma insulin concentration as well. Similarly, the meal sub-model uses [68] model to mimic
the processes of ingestion and the absorption of carbohydrates. Two assumptions have been
made about representing the percentage of glucose in the blood: the rate of gastric emptying
is a trapezoidal function and the intestinal glucose absorption follows the first order linear
kinetics. The parameters in the meal sub-model are obtained from [68] and they are patient-
independent. Finally, the exercise sub-model uses [99] model to simulate the physiological
processes that occur during an exercise event and in the recovery period. Indeed, the authors
developed an algorithm that determines the most significant physical activities performed
by the patient by analyzing the measurements provided by the exercises sensor armband.
Then, the corresponding data of these exercises are fed into the [99] model to simulate the
effects of exercises on BGL. The proposed algorithm in the exercise sub-model provides the
patient an option not to wear the activity monitor continuously throughout the day, but
only during an exercise.
The prediction sub-model uses support vector machines for regression (SVR) [101] and
[12] to predict BGL, due its effectiveness on large and dimensional datasets, which is the
case in glucose prediction problems. The prediction sub-model receives the following inputs
from the mentioned compartmental models: the rate of glucose appearance in plasma after
a meal, the plasma insulin concentration, the physical activity related variables, and the
s.c glucose measurements obtained from CGMS. The predictions are carried out for four
different Prediction Horizons (PH): 15 ,30 ,60 and 120 minutes. The study uses root mean
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squared error (RMSE) and the correlation coefficient r to evaluate the prediction accuracy.
The Clarke’s Error Grid Analysis is also used to evaluate the clinical significance of the errors
between the predictive and measured BGL. The published results demonstrate that the short-
term prediction (15 or 30 minutes) is more accurate and highly correlated with the measured
glucose values (0.95 for 15-minutes PH, and 0.88 for 30-minutes PH). However, the model
performance decreases when the PH increases to 60 or 120 minutes. The two approaches
used to describe the exercise activity produced approximately equal results. Moreover, most
of the predicted glucose points were on zones A and B on Clarke Error Grid Analysis, and
there are no points belonging to the erroneous E zone, which represents clinically acceptable
results. The model has some limitations; it does not consider the effects of fat, protein,
and the glycemic index on the digestive and absorptive processes. Additionally, it does not
consider other factors that affect the insulin absorption and insulin kinetics processes, such
as body temperature. It is worth pointing out that Georga et al.’s model [41] is the first
study that considers the impact of physical exercises on the future predicted BGL, and it
is the first study that fed the exercise model with real sensor data to measure the exercise
intensity.
[108] designed and developed a number of different linear, compartmental neural networks
models for predicting the BGL of diabetic patients. The goal of the paper was to evaluate
the neural network’s technique performance by comparing it with standard models such
as the linear model, and with complex models such as the compartmental model, each of
which simulates all the physiological processes related to diabetes. The following is a brief
description of the proposed compartmental model and the two neural networks models. The
compartmental model (non-linear model) consists of the following sub-models that mimic
human organs’ operations to regulate the BGL in the human body: kidney, blood, liver,
digestive tract, insulin dependent utilization (muscles), and insulin independent utilization
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(red blood cells). Food, insulin, and exercises were the gathered inputs for the model. The
effects of these inputs on BGL were approximated and delayed by linear response functions.
These inputs were mapped to corresponding response functions by a functional block called
Md. Then, the response functions were fed in a second compartment model called Mn
function to simulate the dynamics of the BGL, using a non-linear difference equation. The
non-linear equation models the following interactions of the glucose dynamics: the increase
of the BGL due to consuming carbohydrates, the insulin-dependent glucose production of
the liver, the insulin-dependent usage of BGL, the insulin-independent usage of BGL, the
renal clearance, and the effects of exercises on lowering BGL. The parameters of the model
were not adapted from the training data, but derived from other literature mentioned in
[108].
The used non-linear equation in the Mn functional block is derived from unreliable physi-
ological assumptions that do not simulate all the physiological interactions correctly. There-
fore, the authors replaced the Mn functional block with a Recurrent Neural Networks (RNN)
model to simulate the physiological interactions appropriately. The inputs for the model are
insulin, food, exercise, and the current and previous estimation of the BGL. It has been
chosen due its ability to accept previous predictions as an input and use these measurements
to improve the prediction process. Two different modes were used to run the RNN: free run-
ning (FR) mode and the teacher forced (TF) mode. In the free running mode, the network
predictions were iterated for training and prediction. While in the teacher forced mode, the
measurements of the BGL were substituted for the predicted values whenever available in
the training and prediction phases. Real time recurrent learning rules were used to adapt
the weights in the RNN.
On the other hand, Time Series Convolution Neural-Network Models (TSCNN) has been
proposed to predict BGL. TSCNN is an appropriate solution for applications where past
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measurements are not always available. TSCNN is exploited when there is a desire to avoid
recurrent learning rules and to predict new values without receiving all the past measure-
ments. However, TSCNN may need to receive relevant input that might have occurred a long
time period in the past (in this application, up to 24 hours). Therefore, to limit the input
space, and not end up with a large input space that leads to overfitting, the authors have
added several approaches to determine the appropriate size of the time window to receive
related inputs. These approaches handle the problem either by determining the size of the
window precisely (Hard Limited Time Windows TSCNN-HL) or softly (Soft Competitive
Fixed-Time Windows TSCNN-SC).
Based on the authors’ opinion, predicting BGL applications encounter two essential prob-
lems. The first problem is related to the number of times that BGL is measured each day.
Unfortunately, BGL were measured a few times every day, and therefore the model missed
many BGL measurements (assuming no CGMS has been used in this application). Sec-
ondly, the BGL dynamic system is highly stochastic: such that the standard deviation of
the residual error was around 54 mg/dl in the proposed application. This value is consid-
ered highly significant, especially if we consider that the mean BGL for a healthy person is
around 100mg/dl. Therefore, the authors applied Linear Error Modeling rules (LEM) on all
the proposed models to simulate all the non-linear interactions deterministically, to obtain
better prediction results, and to avoid solving complex integrals that are required for most
stochastic non-linear dynamic models.
As can be seen, Tresp et al. [108] have introduced several different models with differ-
ent variations and complexities. These models are the RNN, RNN-FR, RNN-TF, RNN-
LEM,TSCNN, TSCNN-LEM, TSCNN-HL, TSCNN-SC, compartmental model, compart-
ment model-LEM, and linear model. To evaluate these different predictive models, the
explained variance is used. It was defined as (1 −MSPE(model)/MSPE(mean))), where
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MSPE (model) is the mean squared prediction error on the test set of a certain model, and
MSPE (mean) is the mean squared prediction error of predicting the mean. The results
showed that RNN-LEM gave the best results and outperformed both of the compartment
models and TSCNN approach. The reasons that RNN has better results than the compart-
mental model might be attributed to the greater flexibility obtained using the RNN model,
which does not depend heavily on prior physiological assumptions. Similarly, RNN outper-
formed the TSCNN approach due to the fact that RNN better represents dynamical systems
than models whose predictions only depend on past inputs.
[91] compared the performance of the Multilayer Perception (MLP) neural network and
Elman-RNN in predicting BGL for type I diabetic patients. MLP NN consisted of three
layers of neural networks with a hidden layer that contains five neurons, and one output layer
with one neuron. Neuron active functions of each layer were used to compute the threshold
of the output layer. The logsig activation function was used for the output layer, and the
tansig activation function was used for the hidden layer. The network was trained by a back
propagation method. On the other hand, the Elman RNN has been modified by adding an
additional feedback layer to include past activities in the prediction process. Both models
have the same number of neurons, layers, type of activation functions, and training algorithm.
Moreover, the input set for the two models were the same, and it included the type of
insulin (short acting or long acting), the time between two consecutive glucose measurements,
carbohydrate intakes, exercises intensity, stress levels, and BGL measurement at the start
of the given period of time. The only difference between the two models is the feedback
loops that were added in Elman RNN, as mentioned earlier. The feedback loops provide the
Elman model with an internal memory that remembers the dynamic characteristics of the
inputs.
The mean absolute error between the observed and predicted BGL was used to evaluate
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the two models. The Elman RNN model outperformed the MLP NN model in the prediction
accuracy. The mean absolute of prediction errors for the testing step of Elman RNN was
equal to 1.04 mg\dl, whereas the mean absolute prediction errors for the testing step of
MLP NN was equal to 2.41 mg\dl. The authors attributed the results with the fact that
the current state of BGL in the glucose metabolism depends heavily on the activities that
took place in the past, and the new modification of the Elman RNN satisfies this factor by
its internal memory property.
The Elman neural network has been used with a neuro-fuzzy expert system in [100] to
predict BGL, and it suggests a short term therapy for type I diabetic patients. The system
predicts the next BGL value at time t+1 from the previous measured BGL, anticipated diet,
exercises, and insulin regimen events. It all happened at time t. These inputs and variables
were used to generate the best set of suggested exercises, diet regimen, and insulin regimen to
help the patient reach the targeted BGL. The training of the neural network was performed by
using a back-propagation method, incorporating momentum, and an adaptive learning rate.
The tan-sigmoidal activation function was used in the recurrent layer, whereas the linear
function was used in the output layer. Ninety-five recurrent layer neurons were used to give
the best results. To train the neural network, the following vector inputs were collected from
the patient; the insulin vector that includes the time, the site of the injection, and the type
of the insulin; the diet vector that includes the consumed carbohydrates portion and the
time of meals; the exercise vector that includes the duration, the strength, the endurance,
and the time of exercise; the BGL vector that includes the measurement value, the time
of the measurement, and the prediction time; and finally a vector that contains the stress,
illness, and other parameters.
The network was trained by allowing the patient to enter his\her BGL at time t and
at time t+1. They had to supply the neural network with all of the events (inputs) that
20
occurred between these two times. Then the neural network was trained using the value of
BGL at time t+1. After this, the neural network was presented with the events that occurred
between t+1 and t+2. The neural network was then trained with the BGL value at time
t+2. In other words, the output of the trained network is the BGL of the following event
step.
To evaluate the model, the difference between the prediction value and the actual value
of BGL was computed. A certain value was specified to classify the performance of the
proposed system. It was determined that if the difference value is less than 27mg\dl, then
the performance of the model is classified as satisfactory; otherwise it will be considered as
poor performance. The paper showed that the prediction values and the measured values
were very close for the two cases that the model was tested on, with a difference equal to
27mg\dl or less.
A different and an interesting approach has been discussed in Kok’s thesis [63] to predict
BGL. The proposed system does not use a single neural network model to predict BGL for all
time periods of a typical day. It has been assumed that the accuracy of the prediction depends
mainly on the time of the day predicted and the factors that affect the BGL practically during
that period (factors that influence BGL vary during the day). Moreover, it has been shown
that there is no a particular neural network structure that performs perfectly on all of the
different time periods of a typical day. Therefore, the day has been divided into four different
time periods: morning, afternoon, evening, and night. A different neural network structure
has been applied to each time period. For instance, a small architecture neural network with
a single hidden layer with 2 nodes and a double hidden layer with 1 or 2 nodes in the first
layer was used in the morning period. Moreover, the proposed approach uses a different
set of input variables for each time period. The input variables of the morning period are
different from the input variables of the afternoon, evening, and night periods. The input
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variables of the afternoon period are also different from the input variables of the morning,
afternoon, and evening periods, etc. For example, the inputs for the afternoon period are
BGL, the amount of short acting insulin, food intake, and exercise and stress, while the
input for the morning period are BGL, the amount of short acting insulin, food intake, and
exercise and stress during the interval, long acting insulin over the past 24 hours, exercise
added up squared values during past 24 hours, and the interval length. The Trial and Error
method was used to determine the best input set for each time period. The total number of
the input variables for the whole day was equal to 19 different inputs.
RMSE was used to evaluate the proposed neural network models and the associated
inputs and parameters. Moreover, the performance of the models had been compared in
different aspects, such as the structure of the neural network, the learning rate, and the
model performance. The obtained results showed that the average RMSE for the morning,
afternoon, evening, and night periods were 41.4 mg\dl, 37.8 mg\dl, 43.2 mg\dl, and 41.4
mg\dl, respectively. Furthermore, the best RMSE for the four mentioned time periods were
32.4 mg\dl, 32.4 mg\dl , 37.8 mg\dl, and 39.6 mg\dl, respectively. In other words, the
best achieved prediction accuracies were in the range of 30-40 mg\dl, which is considered a
promising result, specifically when compared to the AIDA’s results [69], which has an RMSE
value equal to 35mg\dl.
Baghdadi’s et al.’s model [8] followed the same methodology applied in Kok’s model [63] to
predict BGL. It divides the typical day into four different time periods and predicts BGL for
each time period separately. The typical day was represented by eight BGL measurement
points that were collected at breakfast, after breakfast, lunch, after lunch, dinner, after
dinner, at night, and before sleeping. Each time period contains three of these measurement
points; the first one was collected at the beginning of the time period, the second one during
the time period, and the last one at the end of the time period. Indeed, the authors used the
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same 19 inputs that were used in Kok’s research work. However, the pruning method was
used to eliminate unimportant inputs for each time period and select the best input set for
each time period. The input variables that have the lowest weight vector were eliminated
for each time period, and those that do not affect the performance factor negatively were
considered as input variables.
The Radial Basis Function (RBF) neural network has been used to predict BGL for each
interval. It consisted of an input layer of source nodes, a hidden layer of high enough di-
mension, and an output layer that provided the response of the network to the activation
patterns applied to the input layer. The average RSME was computed to evaluate the appli-
cation, and the following are the corresponding values for the morning, afternoon, evening,
and night periods: 1.4868 mg\dl, 0.9234 mg\dl, 0.6714 mg\dl, and 0.2124 mg\dl. In addi-
tion, the model outperformed Kok’s model [63] and the AIDA system [69] with an RSME
equal to 0.216 mg\dl. The obtained results, however, need to be verified more by testing the
model on different data sets, and by comparing it with different models.
Following the same methodology in [63] and [8], Zainuddin et al.[116] proposed an expert
system that uses the principal component analysis (PCA) technique, and Wavelet Neural
Network (WNN) to predict BGL for different time periods in a typical day. The same
collected 19 input variables in [63] and [8] were used, and the same methodology of modeling
the day time periods was followed as well. Moreover, Zainuddin et al. proved that inputs that
influence BGL vary during a day (stated in Kok’s thesis too) by calculating the correlation
coefficients R between the BGL of morning, afternoon, evening and night periods. It was
shown that BGL for the morning, afternoon, evening, and night periods were not highly
correlated to each other. For instance, the correlation factor between the morning and
afternoon time periods was 0.1168, which indicated a weak correlation between the two
time periods. These results might be explained by the fact that inputs that influence BGL
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dominate at different time periods. In other words, inputs affect BGL concentrations for a
few hours only, but are not continuous for the rest of the day.
The PCA technique used to extract the set of inputs that significantly affect BGL con-
centrations from the whole collected input sets make all of these correlated extracted inputs
independent of each other. In the proposed application, PCA reduced the number of input
variables from 19 different input variables to four input set for each time period. Three
WNN models were applied to each time period. Each of these models implements a different
embedded wavelet family in the hidden layer. The following wavelet families acted as acti-
vation functions in the hidden layers have been used: Mexican Hat, Gaussian wavelet, and
Morlet. Moreover, the learning method of the neural network was determined by solving
the pseudo-inverse with fixed parameter initialization. To avoid the overfitting problem, the
multifold cross validation technique was used. It is worth pointing out that Zainuddin et al.
model [116] was the first application that uses WNN in modeling BGL variations.
Several wavelet families have been used to predict BGL for each time period. RMSE was
used to compare the performance of these families and to compare the performance of the
application with the performance of [63] and[8]. The experiments showed that the WNN with
Gaussian Wavelet (as activation function) had the best performance with the lowest RMSE
for all the time periods. Therefore, it my be compared with kok’s model and Baghdadi’s et
al.’s model. Zainuddin et al.’s model had better performance than kok’s model, because the
latter used a random selection method to collect the inputs, while Zainuddin et al.’s model
used PCA to extract only the inputs that affect BGL significantly. On the other hand,
the proposed application outperformed Baghdadi et al.’s model in the morning, afternoon,
and evening periods. Combining the Gaussian function with the WNN helped the proposed
application perform better than Baghdadi’s et al.’s model, which uses the Gaussian function
alone in the hidden nodes. However, Baghdadi’s et al.’s model had a better performance in
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the night interval due to the used input selection method that eliminated the past inputs from
previous time periods. PCA considers all the related and valuable inputs that may influence
BGL from past and present user activities, which may span more than 36 hours from the
present glucose measurement, and consequently affect the prediction process negatively.(For
the night interval, the RMSE of Baghdadi’s et al model was 0.2124 mg\dl, whereas for the
Zainuddin et al. model it was 0.306 mg\dl.)
[78][79] proposed an application that combines compartmental models and neural network
models to make short-term BGL predictions. The compartmental model consists of five
physiological models that simulate the effects of different types of injected insulin on plasma
insulin concentration and the effects of consuming carbohydrates on the BGL. Those models
are: Quick Acting (QA) Insulin Kinetics model, Short Acting (SA) Insulin Kinetics model,
Intermediate Acting (IA) Insulin Kinetics model, Long Acting (LA) Insulin Kinetics model,
and a model for glucose absorption from the gut. The outputs of these models, along with the
recent BGL measurements, were used as inputs for the proposed neural network models to
predict BGL. The two proposed neural network models are the Feed-Forward Neural Network
(FFNN) and the RNN. The FFNN was trained by the batched back propagation algorithm
and receives the following inputs: the most recent BGL measurement, the four vectors that
describe the effects of the four types of insulin, and a vector that describes the effect of
food intake. On the other hand, the RNN was trained by the online Real Time Recurrent
Learning algorithm (RTRL), and it receives the following inputs: the current and previous
BGL predictions, glucose concentration into the blood from the gut, and the concentration of
insulin plasma after the injection of any type of insulin. The RTRL algorithm simulates the
dynamic system in real time by updating the weights of the model according to the received
inputs. Two different methods have been used to train the RNN: the Free-Run (FR) method
and the Teacher-Forcing (TF) method. In the RTRL–FR method, the RNN ignores the
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available glucose measurement, while in the RTRL–TF method, the RNN substitutes the
actual output for the corresponding available glucose measurement.
The RMSE, and the correlation coefficient (cc) have been computed for all the proposed
models. The results obtained from the performance assessment showed that the FFNN and
RTRL-TF models performed better than the RTRL-FR model in all the patients’ cases (data
from children with type I diabetes have been used). Although the performance of FFNN was
slightly better than the on-line RTRL-TF model, the authors preferred the on-line RTRL-TF
model due to its ability to adapt the weights when a new input is received.
As we have seen, neural networks have been used intensively to predict BGL and help
diabetic patients to know their future BGL concentrations ahead of time to achieve a better
life style. Indeed, different structures with different input sets have been investigated to
estimate BGL accurately. Some of the proposed methods used the food, exercises and insulin
as input sets for their models ,as we have seen, while other models used unordinary input sets
to estimate BGL for diabetic patients. For instance, [44] used blood glucose concentration,
skin impedance, and heart rate as inputs to the proposed model to simulate BGL variations
for type I diabetic patients. The application used a multilayer feed forward neural network
to make the prediction and back propagation training method to adapt the weights. The
estimated BGL was found to be correlated to the actual BGL with an accuracy within 10%.
On the other hand, other published literature focused only on comparing the performance
of different neural network structures in simulating the glucose dynamic system without
estimating the future BGL. For example, [120] [119] compared the performance of RNN-
Levenberg-Marquardt (LM) and Polynomial Neural Networks (PNN) in simulating BGL.
The two models were fed by the same set of inputs (insulin, exercises, meals, BGL, and
the time period between two consecutive glucose measurements) and were applied under the
same conditions. The results showed that the LM-NN model outperformed the PN model
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due to the type of the gathered data (not a PN type of data), and that the PN model could
not successfully use the patients’ activities to predict BGL.
On the other hand, time series models are used to predict future events based on recent
events that have been gathered at regular time intervals. To utilize time series models in
predicting BGL, the models were recursively defined at each sampling step and incorporated
with a change detection method that enabled dynamic adaptation of the model to inter- and
intra- subject changes and glycemic unsuitability. [15] is one of the first papers that used
time series analysis methods to test whether BGL can be predicted or estimated from past
BGL values. To determine if the BGL values are predictable, it was required to analyze
the BGL data and test if there is a stable or evident structure in the observed data, and if
the data are stationary. The paper used the autocorrelation function (ACF) to study the
correlation between individual data points and measure the dependency between individual
measurements that change over time. The sequence of ACF coefficients depicts the statisti-
cal dependence between the pairs of data separated by fixed-time intervals throughout the
sampling process. If the data were found statistically dependent, this implied that some pre-
dictable structure exists. Moreover, if the process readings had been and remain stationary,
this means that the process can be used to predict future values. The paper ,through a series
of steps, proved that BGL has a structured pattern and it is stationary and predictable. A
linear auto regressive model was used to predict future BGL in general, and to evaluate the
linear predictability of the glycemic dynamics during glycemic disturbances. It was evalu-
ated on different PH values, such as 10, 20, and 30 minutes. The results demonstrate that
the 10- and 30- minute predictions followed the general path of BGL data. However, the
10-minutes prediction was better than the other one. The average root mean squared error
value of predicting BGL with PH equals 10 minutes (under stationary disturbances) was
equal to 3.60 mg\dL, which is considered an acceptable error range. Since this study, most
27
of the published works in this art use the auto-regressive(AR) prediction technique to predict
BGL in utilizing recent BGL values. However, other studies include different inputs such as
exercises and foods to increase prediction accuracy.
[104] built on Bremer and Gough’s model [15] to answer a question regarding the ability
of predicting BGL ahead of time to prevent or avoid hypo\hyperglycemic conditions that
diabetic patients may experience. The study utilized patients’ history BGL data to answer
the question. These data were collected from 28 diabetic patients and monitored every
three minutes for an 48-hour period. A linear model and a first-order AR model have been
used with time-varying parameters. These parameters were calculated using weighted least
squares on every new collected BGL sampling. Moreover, all the sample data were assigned
different weights using the forgetting factor that improves the fit of the most recent data.
Without using the forgetting factor (assigned a small value), it might take hours or days
before the actual sampling time would influence the prediction.
The results proved that BGL can be predicted ahead of time, with a PH equaling to 30
minutes. This time horizon is considered a sufficient margin to take all the needed actions
or treatment steps to recover a diabetic patient from hypo\hyperglycemic symptoms. Two
quantitative assessments were used to compare the two models; the mean square prediction
error (MSPE), and the energy of the second-order difference of the predicted profile (ESOD).
MSPE determines the closeness of the predicted BGL to the measured ones, while ESOD
evaluates the oscillation in the predicted BGL values. Comparing the two models using
MSPE shows that they were close and similar in performance. However, evaluating the
models using the EDOS technique show that the polynomial model was slightly smoother
than the AR model. Another evaluation has been taken to evaluate the effects of increasing
the length of PH on the precision of the prediction. As expected, increasing PH causes a
larger prediction error and q wider oscillation in the predicted BGL. In general, the paper
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preferred Average Glucose (AG) rather than the linear models in many aspects, especially
when the forgetting factor value is considered.
[30] [28] [29] used time-series analysis to design the subject-specific glucose prediction
model. The model is a low-order linear model that predicts BGL with a PH equal to 30
minutes, and it addresses the variabilities and fluctuations of BGL. It was incorporated with
recursive identification and change detection methods to provide a quick adaptive response.
These methods adapted the model dynamically to any changes in BGL and for any glycemic
disturbances. At every BGL sampling, the system updates the parameters dynamically
to reflect new information about the BGL readings. The weighted recursive least square
algorithm is used to implement the recursive identification feature. The algorithm captures
the BGL fluctuations or glycemic disturbances by decreasing the value of the forgetting
factor when a constant change in the models’ parameters is found. This way, past readings
are precluded and faster convergence to new parameters is included. The parameters are not
updated if the changes were not persistent. Moreover, future BGL values are predicted from
the recent readings without requiring any prior information about the glycemic disturbances,
such as meal consumption or insulin administration.
The proposed model in [95] [96] is a multivariate time series model that incorporated
external information regarding insulin, food and physical exercises. It estimates future BGL
by simulating the effects of measured inputs on BGL over a long period of time. The
suggested solution proposed was a causation model that correlates the changes of BGL to the
recent patients’ activities (measured inputs). The measured inputs consist of 24 disturbances
and are grouped into three main sets: food, activity, and stress. However, they have been
reduced to 11 variables that include three food variables, seven activity variables and a time
of day (TOD) variable, which is measured in minutes and represents the number of minutes in
a single day. The effects of each input on BGL was determined independently and in isolation
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of other inputs. However, the data were collected under free-living conditions and these data
in general are highly correlated data. For instance, the carbohydrates and fats variables
in the food set are highly correlated variables; they are usually increased and decreased
together. Moreover, the input data can have non-linear dynamic and interactive impacts on
BGL. The dynamic behavior defined as the delay between the occurrence of the input (food
intake, physical exercises,etc) and the output response (future BGL).The interactive behavior
is described as the modeling process of the effects of two or more variables concurrently on
the desired output. For instance, the exercise event can increase or decrease BGL based on
the food consumption history. Therefore, to model the effects of each input separately and
address the dynamic behavior of the inputs on BGL, the block-oriented Wiener model [94]
was used. In the Wiener model, each input (disturbance) is connected to a dynamic linear,
block which is a set of differential equations. The intermediate output of the dynamic block
is a variable that represents the dynamic response (behavior) of the corresponding input.
These intermediate outputs are then passed into a static non-linear block that computes the
final output, which is the glucose concentration in this context. In other words, the highly
correlated inputs that enter the Wiener model will be broken down to weakly correlated
variables represented by the intermediate dynamic variables. Then the effects of these weak
variables are used to compute the future BGL. For instance, the intermediate variables that
represent the carbohydrates and fats inputs will be weakly correlated, because their inputs
have different dynamic behaviors; carbohydrates have a shorter residence time than the
fats. The model was evaluated by the average absolute error (AAE) performance method.
It computes the absolute difference between the measured glucose concentration and the
modeled glucose concentration. The model was performing well with an AEE of 13.3 mg/dL
and a fitted correlation coefficient of 0.70 for 5 min predictions. The suggested model helps
type I and type II diabetic patients to manage their BGL by modeling the effects of the
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food, physical exercises disturbances, and other various daily activities on the BGL. The
model estimates BGL from 11 measured variables, only without utilizing previous measured
glucose measurements. It is worth mentioning that this study also proposed a sub-model that
predicts BGL by utilizing only the recent glucose measurements. The sub-model predicts
BGL in k-steps-ahead (KSA). The results showed that BGL can be predict accurately when
the number of k-steps is small, or when the PH value is short (less than 60 minutes). However,
its performance degraded when the number of k-steps increased, or when the PH get longer
(more than 60 minutes).
To validate the model, two continuous glucose data sets obtained under hospitalized and
normal daily life conditions were used. The BGL was measured every 5 minutes for an 48
hour period in the two sets. The Sum of Squares of the Glucose Prediction Error (SSGPE)
and Clarke Error Grid analysis (CG-EGA) were applied to validate the model on the two
used sets. It was proved that the model was able to track and predict BGL accurately with
a PH equal to 30 minutes. Since the proposed system has a small number of parameters
and its computations are considered light, it can be integrated in portable devices for early
hypo\hyperglycemic alarms, and for closing the glucose regulation loop with an insulin pump.
The prediction model was used also in [28] to measure the required insulin infusion rate, and
in [29] to predict hypo\hyperglycemic episodes and provide early notifications.
In conclusion, this section covered the significant published literature of predicting BGL
on different aspects and facets. Several shared notes and findings can be summarized in the
following points. A shared common finding between all the studied models is the negative
correlation between the accuracy of the BGL prediction and the PH, where the accuracy of
the prediction decreases when the PH increases. In fact, the most examined range for PH
in the covered models is between 15 minutes to 120 minutes, with 30 minutes as the most
examined value. Moreover, PH is affected directly by the type and kind of the gathered
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inputs, such as exercises, insulin therapy, and\or food components. Nonetheless, few studies
included other inputs that are associated with exercise activity such, as heat flux, galvanic
skin response, energy expenditure (EE), heart rate, rate of perceived exertion, and sleep.
Even though the main goal of most of the investigated models was predicting BGL and\or
hypo\hyperglycemia risks, there are other studies that use a classifier to identify related life-
threatening situations by mapping inputs to pre-established classes of recommendations [85].
Finally, the examined models have a general trend to individualize the prediction process by
considering the personal lifestyle and patients’ physiology to produce more accurate results.
2.3 The preliminary version of CarbMetSim
This section summarizes the preliminary version of CarbMetSim described in Aydas’ dis-
sertation [7]. However, all the aspects of the simulator were redesigned after this preliminary
version as it is described in chapter 3 and chapter 4 [48].
2.3.1 Food and Exercise Description
CarbMetSim represents meals (in the preliminary and recent version) in terms of their
serving size and the quantity of rapidly available glucose (RAG), slowly available glucose
(SAG), protein, and fats per serving. The RAG component consists of sugars and the
rapidly digestible starch (i.e. starch that was digested in vitro within 20 minutes [27],[56]),
whereas the SAG encompass the slowly digestible starch (i.e. starch that was digested in
vitro between 20 and 120 minutes [27],[56]). The preliminary and the current implementa-
tion of CarbMetSim considers the impact of protein and fat in food on gastric emptying,
and this illustrates why the protein and fat components per serving are included in the
food description. However, CarbMetSim in both implementations does not have a detailed
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implementation of protein and lipid metabolism. Also, the simulator does not take into
account the effect of dietary fiber (non-starch polysaccharide part of the carbohydrates) on
gastric emptying, even though fibers in food are known to have an impact on gastric emp-
tying. CarbMetSim does not represent protein in terms of its amino acid contents. Aerobic
exercises are the only exercises that were supported by CarbMetSim. An exercise activity
was described in terms of its intensity in units of METs, where 1 MET is 1 kcal of energy
expenditure per kg of body weight per hour.
2.3.1.1 Modeling Insulin Production
The current insulin level in the preliminary and current implementation of CarbMetSim
is represented by a variable called insulinLevel. In the preliminary implementation of Carb-
MetSim, the value of the insulinLevel was determined using the following four configurable
parameters :
1. baseGlucoseLevel_ : represents the typical fasting BGL of the individual (default value
equals 100 mg/dl).
2. highGlucoseLevel_: represents the typical peak BGL the individual experiences (de-
fault value equals 200 mg/dl).
3. baseInsulinLevel_: represents the insulin level in the blood when the BGL is less than or
equal to baseGlucoseLevel_ (assigned a value between 0 and 1); The baseInsulinLevel_
must be less than or equal peakInsulinLevel_.
4. peakInsulinLevel_: represents the ability to produce insulin (assigned a value between
0 and 1).
This implementation of CarbMetSim assumed a value between baseInsulinLevel_ and
peakInsulinLevel_ for the insulinLevel variable. The peakInsulinLevel_ parameter reflects
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the ability of producing insulin. A value 1 implies a normal insulin production, where a value
0 denotes there is no insulin production (from pancreas) at all. Assigning a value x (between
0 and 1) for the peakInsulinLevel_ variable indicates that the peak insulin production is
just x times the normal peak. The value of the insulinLevel is set according the following
rules. If the BGL is less than or equal to the baseGlucoseLevel_, the insulinLevel stays
at baseInsulinLevel_ . However, the variable increases linearly from baseInsulinLevel_ to
peakInsulinLevel_ as the BGL increases from baseGlucoseLevel_ to highGlucoseLevel_. If
the BGL becomes greater than or equal to highGlucoseLevel_, the insulinLevel stays at
peakInsulinLevel_. This module in the current implementation of CarbMetSim has been
changed and updated dramatically.
2.3.1.2 Modeling Glucose Transport
CarbMetSim models the active and passive glucose transporters. The active transporters
move glucose from a low concentration to a high concentration, while the passive transporters
such as Glucose Transporters (GLUTs) move glucose from a high concentration to a low
concentration. The acutal average amount of glucose that is transfered per minute via active
transporters is computed as a poisson distributed random variable. However, CarbMetSim
uses Michaelis Menten kinetics (described later in Section 3.3) to determine the amount of
glucose transferred in a minute via passive transport. GLUT4 is the passive transporter that
helps the muscles to absorb glucose from the bloodstream. The number of active GLUT4
depends on the insulin level in the bloodstream. This implementation of CarbMetSim models
GLUT4 transporters in the resting state and uses a paramter called glut4Impact to model
the insulin resistance and the reduced activation of GLUT4 transporters in diabetic patients.
The simulator also models the impact of insulin on GLUT4.
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2.3.1.3 Modeling Glucose Consumption (Modeling Glycolysis)
Glycolysis is a process that breaks down glucose to extract energy for cellular metabolism.
In CarbMetSim the following organs uses anaerobic glycolysis to extract energy: Mus-
cles, Liver, Kidneys, Intestine and Blood. Each of the mentioned organs has two con-
figurable parameters: glycolysisMin_and glycolysisMax_. The organ generates at each
tick a poisson distributed random number (x), with glycolysisMin_ as the mean value
and glycolysisMax_ as the maximum value. Then based on the glucose availability in
the organ, the glycolysis process consumes glucose in a tick according to this formula:
x+ insulinImpact ∗ (glycolysisMax_− x). The insulinImpact variable is a factor that in-
creases in value with an increase in the insulinLevel. The simulator also used a configurable
multiplicative parameter called glycolysisImpact_ to modify the glycolysisMax_ parameter
associated with each organ. glycolysisImpact_ is utilized to model the impact of diabetes on
glycolysis flux. Part of the glucose consumed for glycolysis is converted to lactate, which is
then added to the Blood object. The recent implementation of the simulator uses different
parameters and rules to model the glycolysis process.
2.3.1.4 Modeling Gluconeogenesis
gluconeogenesis is a process that takes place in the liver and the kidney. It produces
glucose by consuming lactate, glycerol, glutamine and alanine[56],[74]. Gluconeogenesis nor-
mally happens when the insulin level is low; however, high gluconeogenesis flux may occur
with diabetic patients when their insulin level is high [71],[56]. The preliminary implemen-
tation of the simulator modeled the impact of insulin on gluconeogenesis flux by multiplying
it with a factor that decreases in value with an increase in the insulinLevel. Also, it used
a configurable multiplicative parameter gngImpact_ to model the impact of diabetes on
35
gluconeogenesis flux by modifying the configured gluconeogenesis flux. Only the lactate con-
centration in the blood is being tracked in the simulator. Other substrates are assumed to
be always available in sufficient quantity to allow gluconeogensis to occur.
2.3.1.5 Modeling Liver Glycogen Synthesis and Breakdown
Liver stores excess glucose in the blood during the post-prandial state as glycogen and
it breaks down the stored glycogen. It releases the generated glucose to the blood during
the post-absorptive state. The two mentioned processes help the human body to maintain
glucose homeostasis. The preliminary implementation of CarbMetSim modeled the synthesis
and breakdown processes simultaneously at configured rates modified by two factors each:
the impact of insulin on these two processes, and the affecting of the liverGlycogenSynthe-
sisImpact_ and liverGlycogenBreakdownImpact_ parameters on the glycogen synthesis and
glycogen breakdown processes, respectively. For the glycogen synthesis process, the insulin
factor increases in value with an increase in the insulinLevel. However, for the glycogen
breakdown, the factor decreases in value with an increase in the insulinLevel. The second
factor is used to model the impact of diabetes on glycogen synthesis and breakdown in the
liver by modifying the configured rates multiplicatively.
2.3.2 CarbMetSim Design and Implementation
CarbMetSim is a discrete event simulator that traces how BGL in the human body is
changed after a timed series of diet and exercises activities. The simulator is implemented in
an object-oriented paradigm, where the key organs are represented as classes. This section
covers the design and preliminary implementation of CarbMetSim.
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2.3.2.1 HumanBody
The HumanBody class contains the following organ objects: Stomach, Intestine, Por-
talVein, Liver, Kidneys, Muscles, AdiposeTissue, Brain, Heart, and Blood. At the beginning
of a simulation, the HumanBody uses priority queue to read the food events and its de-
scription. Also, it reads the intensity of different exercise activities in units of METs (into
the same priority queue) and other simulation parameters that impact the operation of the
human body organs. After firing a food event, the simulator adds the consumed food to the
Stomach. Also, the simulator recognizes when there is no food left in the Stomach. The
simulator updates\rest the energy needs of the simulated subject when there is an exercise
event fired and when the simulated subject is in the reseting state, respectively. In other
words, the simulated subject in CarbMetSim can be in any of the following body states:
Fed_Resting, Fed_Exercising, PostAbsorptive_Resting, and PostAbsorptive_Exercising.
2.3.2.2 Blood
CarbMetSim represents the bloodstream via the Blood object. The Blood object ex-
changes glucose and other substrates with various organs. It maintains the following vari-
ables: glucose, lactate, branched AminoAcids, unbranched AminoAcids, insulinLevel vari-
able, and fluidVolume_ (the blood volume in the simulator). CarbMetSim does not maintain
any other hormones in the Blood object other than insulinLevel.
2.3.2.3 Stomach
In CarbMetSim, the gastric emptying process is motivated by [54]. It is a simple mode
that takes into consideration the role of fat\protein in slowing down the gastric emptying
process. When a food event is fired, the consumed food enters the Stomach instantaneously,
and its contents are added to any existing stores of RAG, SAG, protein and fat. CarbMetSim
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assumes that all the food in the Stomach is in the chyme form and this amount of chyme
that leaks to the Intestine (each minute) consists of one part determined using a poisson
distribution (with a default mean 100 mg) and another part proportional to the total amount
of chyme currently present in the Stomach. The proportional part increases linearly with
a decrease in the energy density of the chyme. When the chyme consists entirely of fat
(with energy density 9.0 kcal/g), the minimum value of this proportionality constant is
0.01 (the default value), and it represents the fraction leaking out of the Stomach object
each minute (where chyme consists entirely of fat). On the other hand, when the chyme
consists entirely of carbohydrate (with energy density 4.0 kcal/g), the maximum value is
9.0/4.0 times the minimum value, and it represents the fraction leaking out of the Stomach
each minute. CarbMetSim does not take into account other factors that impact the gastric
emptying process, such as the solid/liquid nature of food and the fiber content. Therefore,
a bolus of chyme leaks from the Stomach into the Intestine every tick until the Stomach is
empty.
2.3.2.4 Intestine
Carbohydrates are converted to one monosaccharide-glucose in the Intestine object. Once
the Intestine receives bolus of chyme object from the Stomach, it digests some amount of its
RAG/SAG component (the amount digested is calculated using normal distributions), such
that most of the RAG/SAG components of a bolus are digested within 20 and 120 minutes
respectively. The generated glucose of the digested RAG/SAG is added to the glucoseInLu-
men variable, where this variable represents the total glucose in the intestinal lumen. The
fat components of the chyme object are simply added to the AdiposeTissue, and the protein
components are added to a common protein pool in Intestine. The Intestine digests a small
amount of the protein and transfers the generated amino acids to the PortalVein. On the
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other hand, the glucose is moved from the intestinal lumen to the enterocytes, and then
from the enterocytes to the portal vein. The Intestine object maintains two variables: glu-
coseInLumen and glucoseInEnterocytes, where these variables represent total glucose in the
intestinal lumen and in enterocytes, respectively. In details, the Intestine moves some glucose
from glucoseInLumen variable to glucoseInEnterocytes variable, so the amount moved has
an active transport component (determined by poisson distribution) and a passive transport
component (determined by Michaelis Menten kinetics). Also, glucose is moved from the
enterocytes (glucoseInEnterocytes) to the portal vein at each tick using Michaelis Menten
kinetics. Finally, the intestinal cells receives some of their energy via glycolysis process. If
the glucose in enterocytes is not sufficient, the extra glucose needed for glycolysis comes from
the Blood object.
2.3.2.5 PortalVein
The portal vein carries blood that moves through the intestinal tract to the liver. Carb-
MetSim represents the portal vein as a separate class from the rest of the circulatory system
(represented by the Blood object) due its special role as a conduit from the intestine to the
liver. PortalVein object carries the glucose and amino acids generated from the food diges-
tion in the Intestine to the Liver. Also,the PortalVein moves all the amino acids received
from the Intestine to the Liver during each tick. Because the portal vein is a part of the
circulatory system, CarbMetSim maintains the glucose concentration of the PortalVein as
rest of the circulatory system, when no new glucose is being received from the intestine.
2.3.2.6 Liver
The Liver’s operations are implemented in the CarbMetSim as following. Liver absorbs
via GLUT2s some glucose from the PortalVein when the glucose level in the PortalVein is
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higher than what is in the Liver. On the other hand, if the glucose concentration in the Liver
is higher than what is in the Blood, some glucose will be released to the Blood via GLUT2s.
The amount of the glucose absorbed/released is determined using Michaelis Menten kinetics.
Liver converts some of the glucose to glycogen and breaks down some glycogen to glucose
in the manner described previously. Moreover, Liver converts excess glycogen to fat, and
stores it in AdiposeTissue when the glycogen level exceeds its maximum configured value
(equivalent to 120 grams of glucose by default). The Liver consumes some glucose for
glycolysis and produces glucose via the gluconeogenesis process. 93% of unbranched amino
acids received from the PortalVein is consumed by the Liver, and the rest (along with all
the branched amino acids) is released to the Blood.
2.3.2.7 Kidneys
One of the significant tasks for the kidneys is filtering the blood from waste and extra
fluid. The kidneys obtain the needed energy for this task from the oxidation and glycolysis
processes. CarbMetSim represents the kidney operations in the Kidneys object. At each
tick, the Kidneys do the following: Glycolysis, Gluconeogenesis, and Glucose Excretion in
Urine. In the later operation, when the glucose concentration in the Blood object increases
from 11 mmol/l (by default [43]) to 22 mmol/l , the glucose excretion in urine increases
linearly from zero to a certain peak level (100 mg/min by default).
2.3.2.8 Muscles
CarbMetSim represents the skeletal muscles in the Muscles class. The preliminary imple-
mentation of CarbMetSim simulates the response to aerobic exercise only. The summary of
the simulator’s operations when the HumanBody is in Fed Resting, PostAbsorptive Resting,
Fed Exercising, or PostAbsorptive Exercising states is as follows.
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The Muscles perform the following operations when the HumanBody is in the Fed Resting
or PostAbsorptive Resting state (during a tick):
1. Glucose Absorption: Where the glucose is absorbed by GLUT4 as stated previously.
Moreover, a basal absorption via GLUT1s happens at a certain configured rate.
2. Glycolysis: A portion of absorbed glucose is consumed via glycolysis and the resulting
lactate is added to the Blood.
3. Glycogen Synthesis: Some of the absorbed glucose is converted to glycogen when the
glycogen store of the Muscles is less than a configurable maximum value.
4. Oxidation: Remainder of the absorbed glucose is consumed via oxidation.
5. Fatty Acid Consumption: Muscles consume fat from the AdiposeTissue to meet the
remaining energy needs when the glycolysis and glucose oxidation processes do not
meet the energy needs during the resting state.
The Muscles perform the following operations when the HumanBody is in the Fed Exer-
cising or PostAbsorptive Exercising state (during a tick):
1. Oxidation: Glucose absorbed from Blood or derived from locally stored glycogen is
oxidized to meet portion of the energy needs of the human body during exercise.
2. Glycolysis: The glycolysis flux increases from the average value (glycolysisMin_) lin-
early with exercise intensity. The peak level (glycolysisMax_) is achieved when the
intensity of the exercise is 18 METs. The glucose 6-phosphate consumed for glycolysis
comes from locally stored glycogen.
3. Fatty Acid Consumption: Muscles consume fat from the AdiposeTissue to meet the
remaining energy needs when the glucose oxidation and glycolysis described above do
not meet the energy needs.
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2.3.2.9 Adipose Tissue
The AdiposeTissue in CarbMetSim serves as the storage for fat. The Liver converts
excess glycogen to fat and then stores it in the AdiposeTissue. Also, the Intestine object
adds the fat contents in chyme to the AdiposeTissue object. The Muscles object removes
fat from the AdiposeTissue to meet the energy needs. CarbMetSim does not have detailed
implementation of the lipid metabolism.
2.3.2.10 Brain
The brain uses GLUT3 transporters to absorb glucose from the bloodstream and oxidizes
glucose to meet the energy needs. The brain oxidizes about 120 g of glucose per day, which
is equivalent to absorbing 83.33 mg of glucose per minute [57]. CarbMetSim models the
brain operation in the Brain class, where the Brain object consumes on average 83.33 mg of
glucose every minute from the Blood object.
2.3.2.11 Heart
The heart meets most of its energy needs by oxidizing fatty acids. Also, it utilizes glucose
and lactate to meet up to 30% of the its energy needs[57]. The Heart object in CarbMetSim
models the heart operation. It absorbs glucose to meet its energy needs during the fed state.
As mentioned previously, all the aspects of the simulator were redesigned after this pre-
liminary version as it is described in subsequent chapters.
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Chapter 3
Key Aspects in CarbMetSim design
This chapter describes the key aspects of CarbMetSim’s design.
3.1 Food, Exercise and Human Subject Description
CarbMetSim represents meals in terms of their serving size and the quantity of rapidly
available glucose (RAG), slowly available glucose (SAG), protein and fats per serving. The
RAG component consists of sugars and the rapidly digestible starch (i.e. starch that was di-
gested in vitro within 20 minutes [27],[56]), whereas the SAG encompass the slowly digestible
starch (i.e. starch that was digested in vitro between 20 and 120 minutes [27],[56]). The di-
etary fiber (non-starch polysaccharide part of the carbohydrates) is currently not considered
or represented in the simulator, even though fibers in food are known to have an impact on
gastric emptying. Also, the simulator does not have a detailed implementation of protein and
lipid metabolism. It provides a model of the impact of protein and fat contents of food on
gastric emptying. Therefore, the total amount of protein and total amount of fat per serving
is listed in the food description, which is one of the input files to the simulator. CarbMetSim
presently does not represent protein in terms of its amino acid contents. Gleeson [45] stated
that 3 of the 20 amino acids have branched chains; therefore a general assumption is made
that 85% of amino acids that come from protein digestion have unbranched chains and the
remainder have branched chains.
Aerobic exercises are the only exercises that can be simulated by CarbMetSim. An
exercise activity is described in terms of its intensity in units of METs, where 1 MET is
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1 kcal of energy expenditure per kg of body weight per hour. By convention, 1 MET is
considered equivalent to 3.5ml of oxygen consumption per kg of body weight per minute. In
general, each person consumes oxygen up to a certain rate. This personalized maximal rate,
called (%V O2max), depends on the following factors or attributes of the individual being
simulated: gender, age and fitness level of the individual [58].
Representing the intensity of a physical activity in terms of the associated oxygen con-
sumption rate determines the relative fraction of the glucose and fatty acids oxidized to meet
the energy needs of the exercising muscles. Note that the intensity reported as the % age of
the individuals (%V O2max), and it represents the specific oxygen consumption rate associ-
ated with each individual. Therefore, CarbMetSim needs to know the gender, age and fitness
level within the age group of the individual being simulated to estimate the (%V O2max) for
the individual using the tables in Kaminsky, et al. [58].
3.2 Modeling Insulin production
BGL is one of the main factors that determines the insulin level in the blood. If the
BGL is high, the insulin level will increase in order to simulate the liver and the muscle
tissues to absorb glucose from the blood, and also to signal both the liver and the kidneys
to minimize or halt the endogeneous glucose production through glycogen breakdown and
gluconeogenesis processes. On the other hand, the insulin level in the blood decreases when
an individual physically exercises, [110],[102],[111], [39],[115], and therefore the liver and the
kidneys in response increase the production of glucose.
CarbMetSim uses a variable called insulinLevel (inside the Blood object) to represent the
current insulin level in the blood, and it assigns values between 0 and 1 to the variable. The
value of insulinLevel depends on the following variables:
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1. current BGL,
2. the current exercise intensity (in %V O2max),
3. and other configurable parameters:
(a) minGlucoseLevel_: represents typical hypoglycemic BGL.
(b) baseGlucoseLevel_: represents typical fasting BGL.
(c) highGlucoseLevel_: represents typical peak BGL, where (minGlucoseLevel_ <
baseGlucoseLevel_ < highGlucoseLevel_).
(d) baseInsulinLevel_: represents the typical fasting insulin level.
(e) peakInsulinLevel_: represents typical insulin level when BGL is at peak, where
where 0 ≤ baseInsulinLevel_≤ peakInsulinLevel_≤ 1.
(f) restIntensity_: represents the oxygen consumption rate in %V O2max when the
individual is in rest state (not exercising), by default 2 METs converted to%V O2max.
(g) intensityPeakGlucoseProd_: represents the exercise intensity in %V O2max at
which the liver and kidney produce glucose at the maximum rate (by default
20%).
CarbMetSim uses the following rules to determine the value of insulinLevel :
1. if the current BGL is less than or equal to the minGlucoseLevel_, the insulinLevel
stays at value zero.
2. if the current BGL is between the minGlucoseLevel_ and the baseGlucoseLevel_,
the insulinLevel depends on if the human subject being simulated is currently engaged
in physical activity or not. If the human subject is practicing and the exercise intensity
is greater than or equal to intensityPeakGlucoseProd_, the insulinLevel stays at zero.
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On the other hand, the insulinLevel depends on the exercise intensity. As the ex-
ercise intensity decreases from intensityPeakGlucoseProd_ to the the restIntensity_,
the insulinLevel increases linearly from zero to the baseInsulinLevel_ However, If the
individual is in the rest state (not exercising), and the BGL increases from minGlu-
coseLevel_ to baseGlucoseLevel_, the insulinLevel increases linearly from zero to the
baseInsulinLevel_.
3. In the time the BGL increases from the baseGlucoseLevel_ to the highGlucose-
Level_, the insulinLevel increases linearly from the baseInsulinLevel_ to the peakIn-
sulinLevel_.
4. If the BGL is greater than or equal to the highGlucoseLevel_, the insulinLevel
stays at the peakInsulinLevel_ value.
As discussed earlier, the peakInsulinLevel_ variable represents the peak ability to pro-
duce insulin. When peakInsulinLevel_ equals 1, this means that the pancreas produces a
normal (or excessive, as in the case of initial stages of type II diabetes) production of in-
sulin. However, assigning a value 0 to peakInsulinLevel_ means that the pancreas does not
produce any insulin at all (type I diabetes). Assigning a value x (between 0 and 1) to the
variable means that peak insulin production is just x times the normal peak.
The value of insulinLevel should be understood as the impact it has on various organ
objects, rather than the absolute insulin concentration associated with a particular human
subject. Indeed, the variable has a deep impact on the operation of different organ objects in
CarbMetSim. In other words, it is not unexpected to have two different insulin concentrations
for two individuals, in which both of them have the same value for the insulinLevel, because
they have the same impact on carbohydrate metabolism related functions of the organs.
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3.3 Modeling glucose transport
Two types of glucose transporters help in moving glucose into human body cells. The
first type is the active transporters that move glucose from a low concentration to a high
concentration, such as Sodium GLucose coTransporters (SGLTs) . The second type, are the
passive transporters, such as Glucose Transporters (GLUTs) that move glucose from a high
concentration to a low concentration.
The operation of active transporters in an organ is modeled by specifying the average
amount of glucose transferred per minute via active transport. The actual amount transferred
is a poisson distributed random variable. On the other hand, the simulator employ Michaelis
Menten kinetics to set the amount of glucose transferred in a minute via passive transport.
According to Michaelis Menten kinetics, the rate of transport (V) across a membrane depends
on the difference in the substrate concentration (Y) across the membrane in the following
manner: V = Vmax YY+km , where Vmax is the maximum rate of transport and km is the
substrate concentration difference at which the transport rate is half the maximum. The
simulator uses the Vmax value associated with a GLUT transporter in an organ to determine
the number of transporters involved, and it treats the Vmax (associated with a particular
GLUT in a particular organ) as a poisson distributed random variable with a configurable
mean.
There are many types of GLUT transporters in the human body, and one of them is
the GLUT4 transporters. These transporters allow muscles to absorb glucose from the
bloodstream, and therefore they play a main role in moving glucose into cells. GLUT4
transporters are activated by two different ways, depending on the status of the individual. If
the individual is in the rest state (not exercising), the number of active GLUT4 transporters
depends on the insulin level in the bloodstream. When the insulin level is low, GLUT4
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transporters are inactive and the muscles do not absorb enough glucose from the bloodstream.
GLUT4 transporters get active when the insulin level rises in the blood, and which makes the
muscles to absorb excess glucose from the blood. On the other hand, GLUT4 transporters
are activated when the human subject is engaged in physical activity. The exercise itself
activates a sufficient number of GLUT4 transporters [93],[46],[112] to simulates muscles to
absorb the needed amount of glucose from the bloodstream. The simulator replicates both
behaviors. Indeed, CarbMetSim models the GLUT4 activation during the resting states by
configuring the Vmax value associated with GLUT4 transporters in the following manner:
1. Since muscles convert and store a large fraction of the absorbed glucose to glycogen and
there is a limit on the amount of stored glycogen inside muscles, the current amount
of muscle glycogen impacts the Vmax value. In particular, when the muscle glycogen
storage increases from zero to a configurable maximum value, the Vmax value reduces
linearly from a configurable maximum (7 mg/kg/min by default) to a configurable
minimum (3.5 mg/kg/ min by default).
2. The impact of the insulin level is modeled by multiplying the Vmax value with a factor
that increases in value with an increase in the insulinLevel. The insulinLevel itself is
used as the value of this factor, and it is assigned values between between 0 and 1.
Intense physical exercise causes a temporary increase in glucose absorption by muscles
[3] to make up for the glycogen lost during exercise, therefore the insulinLevel does not
impact the Vmax value in the first hour after a robust physical exercise activity (except
if the current BGL is below the baseGlucoseLevel_).
3. The impact of insulin resistance in reducing the activation of GLUT4 transporters is
modeled by multiplying the Vmax value with a configurable parameter (glut4Impact_)
that assumes values between 0 and 1 (by default 1.0).
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3.4 Modeling glycolysis
Human tissues depend on glucose as one of the main sources of energy to maintain their
metabolisms. Human cells either oxidize glucose completely or consume it anaerobically via
the process of glycolysis. Aerobic metabolism (complete oxidation of glucose) generates 15
times more energy than anaerobic glycolysis, but it can only happen if oxygen is available.
Tissues with access to sufficient amounts of oxygen oxidize glucose for their energy needs,
whereas others use glycolysis. The following are the organs that use anaerobic glycolysis as
an energy source in CarbMetSim: Muscles, Liver, Kidneys, Intestine and Blood. The insulin
level in the bloodstream determines the amount of glucose consumed for glycolysis process.
In other words, the consumed amount of glucose increases with the glucose availability (high
insulin levels). The simulator models this process in the following manner:
1. There are two configurable parameters for each organ using glycolysis as an energy
source: glycolysisMin_ and glycolysisMax_. These parameters are in units of mg of
glucose consumed per kg of body weight per minute.
2. At each tick, the organ generates a poisson distributed random number (min) with
glycolysisMin_ as the mean value and glycolysisMax_ as the maximum value. Then,
based on the glucose availability in the organ, the amount of glucose consumed in a
tick for glycolysis is given by: min+ insulinImpact ∗ (glycolysisMax_−min). The
insulinImpact is a factor that is assigned a value between 0 and 1. It increases in value
with an increase in the insulinLevel, and it is calculated using a sigmoid function, which
is currently the CDF of a normal distribution with a configurable mean and standard
deviation.
3. To model the impact of diabetes on glycolysis flux, CarbMetSim uses configurable
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multiplicative parameters glycolysisMinImpact_ and glycolysisMaxImpact_ (with de-
fault values 1.0) to modify the values of glycolysisMin_ and glycolysisMax_ parameters
associated with each organ.
The glycolysis process generates lactate, which serves as a key substrate for endogenous
glucose production via gluconeogenesis (discussed later). Indeed, a fraction (by default 1) of
the glucose consumed for glycolysis is converted to lactate, and added to the Blood object.
Table 3.1 shows the default values for glycolysis related parameters for different organs. The
relative contributions of different organs towards overall glycolysis flux were set as suggested
in [43][113]. The default values of various configurable parameters in CarbMetSim were
determined experimentally to provide a close match with published measurements performed








Table 3.1: The default values for glycolysis related parameters in
various organs.
3.5 Modeling gluconeogenesis
When the human body is not receiving new glucose via food and the glycogen store in
the liver has been exhausted, the glucose is produced through a different metabolic pathway
called gluconeogenesis. This metabolic pathway motivates the liver and kidneys to produce
glucose from lactate, glycerol, glutamine and alanine [37],[75]. Typically, gluconeogenesis
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occurs when the insulin level is low. However, diabetic people may experience high gluco-
neogenesis flux even when the insulin level is high[71][90].
The Liver and the Kidneys (in CarbMetSim) produce glucose via gluconeogenesis using
the substrates mentioned above. CarbMetSim assumes that the substrates are always avail-
able in sufficient amounts to allow gluconeogenesis to take place. The simulator uses two
configurable average rates to produce glucose; gngLiver_ and gngKidneys_ with a default
value equal to 0.16 mg/kg/minute for each parameter.
CarbMetSim models the process of producing glucose via the gluconeogenesis pathway. If
the insulinLevel is above the baseInsulinLevel_, the average gluconeogenesis flux is multiplied
by a factor that has a value between 0 and 1. This factor decreases in value with an increase
in the insulinLevel as per an inverse sigmoid function (currently, the complementary CDF of
a normal distribution with a configurable mean and standard deviation). This simulates the
process of the decrease in gluconeogenesis flux with an increase in the insulin level. On the
other hand, the simulator models the increased gluconeogenesis flux when BGL is low and
gluconeogenesis is probably the only source of glucose for the body. If the insulinLevel is
below the baseInsulinLevel_, the average gluconeogenesis flux is multiplied by a factor that
decreases in value from a configurable maximum (gngImpact_ ≥ 1, by default 6.0) to the
minimum value 1 as the insulinLevel increases from zero to the baseInsulinLevel_.
3.6 Modeling Liver glycogen synthesis & breakdown
The liver plays an important role in monitoring and maintaining normal blood glucose
concentrations. The liver stores and converts excess glucose in blood as glycogen when
the insulin levels are high (during the post-prandial state). Also, the liver breaks down
the stored glycogen and releases glucose to the blood when the insulin level is low (during
the post-absorptive and exercising state). Diabetes may effect both glycogen synthesis and
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breakdown in the liver.
The exact amount of glycogen synthesized by the Liver object during each tick is a poisson
distributed random variable with a configurable average (glucoseToGlycogenInLiver_, 4.5
mg/kg/min by default). The amount of synthesized glycogen depends on the availability of
glucose; also the poisson variable is modified multiplicatively by two factors. The first one
models the effect of insulin on glycogen synthesis. The factor is assigned values between 0 and
1, and it increases in value with increases in the insulinLevel. It is calculated using a sigmoid
function, which is currently the CDF of a normal distribution with a configurable mean and
standard deviation. The second factor called liverGlycogenSynthesisImpact_ modifies the
configured average multiplicatively to model the impact of diabetes on glycogen synthesis
in the Liver. It has value 1.0 as a default. The Liver object has a limited capacity to store
glycogen, and hence any excess glycogen is converted to fat and stored in the AdiposeTissue.
As mentioned above, the glycogen breakdown in the liver serves as the key source of
glucose, so the body does not run out of glucose, especially when no new glucose via food
is entering the body or when the body is experiencing an intensive physical exercise, and
the glucose needs of the body is high. Therefore, the amount of glycogen stored in the
Liver that is broken down to glucose during a tick closely depends on the insulinLevel. In
CarbMetSim, the average glycogen breakdown flux in the Liver is represented by glycogen-
ToGlucoseInLiver_ variable (0.9 mg/kg/min by default). When the insulinLevel is above
the baseInsulinLevel_, the average glycogen breakdown flux in Liver is multiplied by a fac-
tor (between 0 and 1) that decreases in value with increases in the insulinLevel as per an
inverse sigmoid function, which is currently the CDF of a normal distribution with a con-
figurable mean and standard deviation. Typically, this occurs when the BGL is more than
the baseGlucoseLevel_, to model the decrease in Liver glycogen breakdown when there is an
increase in the insulin level. On the other hand, the simulator models the increased Liver
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glycogen breakdown when BGL is below the baseGlucoseLevel_. If the insulinLevel is below
the baseInsulinLevel_, the average Liver glycogen breakdown flux is multiplied by a factor
that decreases in value from a configurable maximum (liverGlycogenBreakdownImpact_ ≥ 1,




CarbMetSim design and implementation
CarbMetSim is a discrete event simulator that tracks the changes of BGL of a human
subject after a timed series of diet and exercises activities. The simulator is implemented
in an object-oriented paradigm, where the Key organs are represented as classes in the
CarbMetSim. On top of these classes, the simulator has a SimCtl (SIMulation ConTroLler)
class and a HumanBody class. The SimCtl contains a data structure of type a priority queue
that stores the food/exercise events sorted in order of their firing times. Also, the class
maintains the simulation time in ticks, where each tick is a minute. At the beginning of the
simulation, the SimCtl object reads all the food/exercise events into the priority queue. At
each tick, the SimCtl object fires the events whose firing time has arrived. Once the event
has fired, the simulator invokes the appropriate methods of the HumanBody class, and then
makes each organ to do its work during the tick time.
In this chapter, the implementation and the operation of the different classes (the roles
of organs) of the simulator are discussed and described. The default values of different
parameters mentioned in this chapter were determined experimentally to provide a close
match with published measurements performed on non-diabetic human subjects before and
after a meal event [114]. Table 4.1 shows the default values of configurable parameters that
determine the effect of insulinLevel on various metabolic processes.
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4.1 HumanBody
The HumanBody class contains the following organ objects: Stomach, Intestine, Por-
talVein, Liver, Kidneys, Muscles, AdiposeTissue, Brain, Heart and Blood. At the beginning
of a simulation, the HumanBody object does the following:
1. It reads the constituents of the consumed foods in terms of rapidly/slowly available
glucose (RAG/SAG), protein and fat.
2. It reads the intensity of different exercise activities in units of METs.
3. It calculates the maximal rate of glucose consumption (%V O2max), associated with
the human subject being simulated using the tables in [58]. The simulator is supplied
with the parameters of the individual’s (being simulated) gender, age and self-assessed
fitness level within his\her age group.










Table 4.1: Configurable parameters (and their default values) for the
mean and standard deviation of normal distributions to determine
the impact of insulinLevel on various metabolic processes.
The SimCtl object calls a HumanBody’s method at each tick. This method causes other
methods to engage with individual organ objects that allow the organs to do their work
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during that tick. The HumanBody (through methods) adds the consumed food to the
Stomach when SimCtl fires a food event; also, it get notified by the Stomach when there
is no food left. On the other hand, the HumanBody updates the energy needs of the body
when SimCtl fires an exercise event. When the exercise event ends, the HumanBody resets
the energy needs to the resting state. Therefore, the HumanBody remembers whether the
Stomach has some undigested food (Fed) or not (PostAbsorptive) and whether the body is
currently engaged in exercise (Exercising) or not (Resting). The simulated human subject
in CarbMetSim can be in any of the following body states: Fed_Resting, Fed_Exercising,
PostAbsorptive_Resting and PostAbsorptive_Exercising. The simulator is configurable to
allow different values for the configurable parameters that control the operation of the organs
based on the current body state (Fed_Resting, Fed_Exercising, PostAbsorptive_Resting
and PostAbsorptive_Exercising).
4.2 Blood
CarbMetSim represents the bloodstream via the Blood object, where the object collabo-
rates with various organs to exchange glucose, amino acids and other substrates. The Blood
object maintains the following substrate variables: glucose, lactate, branched AminoAcids
(consumed by muscles, adipose tissue and brain) and unbranched AminoAcids. The Blood
object also maintains the insulinLevel variable and a variable representing the blood volume
(5 liters by default) called fluidVolume_ . CarbMetSim maintains the insulin hormone only.
At each tick, the Blood object updates the insulinLevel as described in Section 4.2. Also,
some glucose is consumed for glycolysis in the manner described in Section 4.4.
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4.3 Stomach
The process of emptying food from the stomach into the intestine is known as the gastric
emptying process. Gastric emptying is a complicated process and it is affected by several
factors such as the volume, particle size, viscosity, osmolarity, acidity and nutritional contents
of the meal [70], [76] [52]. Several mathematical models have been proposed simulating the
gastric emptying process. For instance, [73], [53] proposed exponential models, where [26]
suggested power exponential functions. Other complicated models were proposed too. For
example, [23] suggested a three-compartment model of the gastrointestinal tract where the
gastric emptying rate follows a trough-shaped pattern (initially high followed by a non-linear
decrease to a minimum value followed by a non-linear increase back to the initial maximum
value). Moreover, [68] proposed a simple model for gastric emptying of carbohydrates in
a meal, where the rate of gastric emptying has three phases—a linear increase phase, a
constant maximum rate phase and a linear decrease phase.
In CarbMetSim, the gastric emptying process is motivated by [54]. It is a simple mode
that takes into consideration the role of fat\protein in slowing down the gastric emptying
process. When a food event is fired, the consumed food enters the Stomach instantaneously,
and its contents are added to any existing stores of RAG, SAG, protein and fat. CarbMetSim
assumes that all the food in the Stomach are in the chyme form and that the amount of
chyme leaking to the Intestine each minute consists of one part determined using a poisson
distribution (with a default mean 500 mg) and another part proportional to the total amount
of chyme currently present in the Stomach. The proportional part increases linearly with a
decrease in the energy density of the chyme. When the chyme consists entirely of fat (with
energy density 9.0 kcal/g) the minimum value of this proportionality constant is 0.03 (the
default value) and it represents the fraction leaking out of the Stomach object each minute.
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On the other hand, when the chyme consists entirely of carbohydrate (with energy density
4.0 kcal/g), the maximum value is 9.0/4.0 times the minimum value, and it represents the
fraction leaking out of the Stomach each minute. CarbMetSim does not take into account
other factors that impact the gastric emptying process, such as solid/liquid nature of food,
and the fiber content. Therefore, a bolus of chyme leaks from the Stomach into the Intestine
every tick until the Stomach is empty. The nutritional composition of leaked chyme is the
same as that of chyme present in the stomach.
4.4 Intestine
The following are the main four operations that occur in the Intestine object in Carb-
MetSim:
Carbohydrate Digestion:
The intestine uses different enzymes to digest the carbohydrates in the chyme (re-
ceived from stomach) to produce monosaccharides such as glucose, fructose and galactose
[57]. CarbMetSim converts all the carbohydrates in the chyme to just one monosaccha-
ride—glucose. With every tick, the Intestine receives a bolus of chyme from the Stomach
as long as there is some food in it. The Intestine class maintains a list of Chyme objects
where each object includes the undigested RAG / SAG contents of each bolus obtained
from the Stomach and the moment it acquired the bolus. Moreover, the Intestine digests
a certain amount of RAG / SAG from a Chyme entity at each tick. The amount digested
from a specific Chyme object is determined using normal distributions with default mean
and standard-deviation, as follows: 2 minutes & 0.5 minutes for RAG and 30 minutes &
10 minutes for SAG. Most of the RAG and SAG contents of the bolus are digested within
20 and 120 minutes, respectively, after the bolus has entered the Intestine. The produced
glucose from the Carbohydrate digestion is added to a variable (in Intestine object ) called
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glucoseInLumen. The variable represents the total glucose present in the intestinal lumen.
Fat and Protein Digestion: When the Intestine receives a chyme bolus, it adds its fat
contents to the AdiposeTissue. Also, it adds the protein contents to a common protein pool
in the Intestine. The Intestine object, at each tick, digests an amount of this protein and
transfers the resulting amino acids to the PortalVein. This digested amount is determined
as per a poisson distribution with a default mean 1 mg. The simulator does not keep track
of the dietary protein’s amino acid composition and makes a simple assumption that 85% of
these amino acids are unbranched and the remaining 15% are branched.
Glucose Absorption from Intestine to PortalVein: Glucose moves from the in-
testinal lumen to the enterocytes through the border membrane of the brush and from the
enterocytes to the portal vein through the basolateral membrane. The transmission from the
intestinal lumen is carried out by the combination of active (SGLT-1) and passive (GLUT2)
transporters in which the amount of GLUT2 transporters is dependent on the level of the
glucose on the lumbar side. However, the transfer from the enterocytes to the portal vein
takes place solely via passive GLUT2 transporters [57]. CarbMetSim uses two variables,
glucoseInLumen and glucoseInEnterocytes, inside the the Intestine object, to represent the
total glucose present in the intestinal lumen and in enterocytes, respectively. At each tick,
the Intestine moves some glucose from the glucoseInLumen variable to glucoseInEnterocytes
variable. The amount moved has an active transport component and a passive transport
component. The active component is determined via poisson distribution, where the default
mean equals 30 mg/minute. The passive transport component is determined using Michaelis
Menten kinetics (assuming configurable volumes for the lumen and the enterocytes). The
Vmax value used for Michaelis Menten kinetics increases with glucose levels in the lumen with
a default maximum value of 800 mg/minute. The Km value used is 20 mmol/l by default
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[57]. The transfer of glucose from the enterocytes to the portal vein is determined by trans-
ferring some glucose from glucoseInEnterocytes, at each tick, to the PortalVein. The amount
moved is determined using Michaelis Menten kinetics (average Vmax= 800 mg/ minute, Km
= 20 mmol/l by default [57]).
Glycolysis: In the way mentioned in Section 4.4, the intestinal cells get some of their
energy via glycolysis of glucose. If the glucose in enterocytes (glucoseInEnterocytes) is not
enough, the extra glucose needed for glycolysis comes from the bloodstream (the Blood
object).
4.5 PortalVein
The portal vein carries blood that passes through the intestinal to the liver. CarbMetSim
treats the portal vein as a separate class from the rest of the circulatory system (represented
by the Blood class), due to its particular role as a conduit from the intestine to the liver.
CarbMetSim passes the glucose and amino acids, resulting from food digestion in the Intes-
tine, to the Liver through the PortalVein. Because the portal vein is part of the circulatory
system, where no new glucose is obtained from the Intestine, the portal vein must have
the same glucose concentration as the rest of the circulatory system. It is implemented in
the following way with CarbMetSim. At the beginning of a tick, there is no glucose in the
PortalVein. During each tick, the following sequence of actions take place:
1. The PortalVein imports glucose from the Blood. The glucose levels in the PortalVein
must match the glucose levels in the Blood before the import process. The PortalVein’s
volume is a configurable parameter with default value 5 dl. It is used to calculate the
glucose concentration.
2. The transfer of glucose takes place from the Intestine to the PortalVein (as described
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previously) and then from the PortalVein to the Liver (described later).
3. After this, any glucose remaining in the PortalVein is transferred back to the Blood.
Also, CarbMetSim moves all the amino acids received from the Intestine to the Liver
during that tick itself.
4.6 Liver
When the glucose level in the portal vein is high, the cells in the liver absorb glucose
from the portal vein through GLUT2s transporters. The absorbed glucose is phosphorylated
to glucose 6-phosphate, which will be used for glycogen synthesis or glycolysis. In the liver,
the Insulin hormone and glucose activate glycogen synthesis enzymes and block the glycogen
breakdown enzymes. Moreover, the insulin hormone activates the glycolysis of glucose 6-
phosphate in liver cells to produce pyruvate, some of which is oxidized, and the remaining is
converted to lactate and released to the bloodstream. However, insulin insufficiency activates
the process of glycogen breakdown and the gluconeogenesis process (as described in chapter
4). The gluconeogenesis flux increases with the availability of the lactate, alanine, glycerol,
and other substrates in the bloodstream even if the level of insulin is high. If the glucose
levels and insulin levels are high, the liver uses the excess glucose for synthesizing glycogen.
However, if the insulin level is low, the excess glucose may leave the liver cells via GLUT2s
and probably other means. Also, a high insulin levels make some of the excess glucose to be
converted into lipid. The main roles of the liver in the fed and post-absorptive states can
be summarized as follows. During the fed stage, the liver absorbs glucose and uses this for
glycogen synthesis and glycolysis. However, during post-absorptive and exercise states, the
liver releases glucose to the bloodstream though the glycogen breakdown and gluconeogenesis
processes. Another essential operation of the liver is its oxidation of unbranched amino acids,
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which supplies nearly half the energy requirements of the liver.
The Liver class in CarbMetSim implements the aforementioned operations of the liver. It
maintains the initial and the allowable maximum amount of stored glycogen as configurable
variables (parameters). The initial value of this variable guarantees that the Liver is able to
produce 100 grams of glucose at the beginning of a simulation. However, the upper default
amount of allowable stored glycogen in the Liver is equivalent to 120 grams of glucose.
The Liver object does the following at every tick:
1. Glucose Absorption\Release: When the glucose level in the PortalVein is greater than
in the Liver, some glucose will be absorbed into the Liver by GLUT2 transporters.
Likewise, if the concentration of glucose in the Liver is higher than into the Blood,
GLUT2 transporters transfer some glucose to the Blood. The amount of glucose ab-
sorbed\released is calculated using Michaelis Menten kinetics (Vmax = 50mg/kg/min
by default and Km = 20 mmol/l by default) [57]).
2. Glycogen Synthesis\Breakdown: The Liver synthesizes or breaks down glycogen in the
particular way described in Section 4.6.
3. Lipogenesis: If the Liver glycogen production meets its configurable maximum value,
the excess glycogen is converted into fat that is stored in AdiposeTissue.
4. Glycolysis and Gluconeogenesis: The Liver absorbs some glucose for glycolysis and
produces glucose through gluconeogenesis, as stated in in Section 4.4 and Section 4.5,
respectively.
5. Amino Acid Consumption: The Liver absorbs 93% of the unbranched amino acids ob-
tained from the PortalVein and transfers the remainder togather with all the branched
amino acids to the Blood.
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4.7 Kidneys
One of the significant tasks for the kidneys is filtering the blood from waste and extra fluid.
This task requires considerable energy. In general, the kidneys obtain the needed energy from
oxidation and glycolysis processes. Their outer layer (the cortex) is well supplied with oxygen
and therefore meets its energy needs through the oxidation of the absorbed glucose and fatty
acids from the bloodstream. The inner center (the medulla) gets its energy from anaerobic
glycolysis. Moreover, the kidneys produce glucose through gluconeogenesis. CarbMetSim
simulates the main operations of the kidney through the Kidneys class. The Kidneys object
do the following at every tick:
1. Glycolysis: The kidney fulfills its energy requirements through glycolysis, as mentioned
in Section 4.4. The glucose consumed for glycolysis is removed from the Blood object
and the resulting lactate is released into the Blood object.
2. Gluconeogenesis: The Kidneys produce glucose via gluconeogenesis in the way de-
scribed in Section 4.5, and they release it to the Blood object.
3. Glucose Excretion in Urine: As the the BGL rises from one Glucose threshold (11
mmol/l) to another (22 mmol/l by default)[43], [77], the glucose excretion in urine
increases linearly from zero to a certain peak level (100 mg/min by default). The
simulator uses a configurable variable excretionKidneysImpact_ (with default value 1)
to multiplicatively modify the amount of glucose excreted per tick in urine.
4.8 Muscles
There are two types of cells or fibers in the skeletal muscles: the red fibers and the
white fibers. To meet the body’s energy needs, the red fibers oxidize fatty acids and glucose
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absorbed from the bloodstream. Muscles mainly use insulin-sensitive GLUT4 transporters to
absorb glucose from the bloodstream. Also, it uses GLUT1 transporters for some basal-level
absorption. The white fibers, however, rely on glycolysis of glucose 6-phosphate obtained
from the glycogen stored within the white fibers. Moreover, the skeletal muscles get their
energy from the absorbed branched chain amino acids.
As stated previously, each individual can consume oxygen up to a certain maximal rate.
This rate is called %V O2max and the rate depends on the gender, age and fitness level
of the individual [58]. Therefore, the intensity of a physical activity can be expressed by
this oxygen consumption rate (%V O2max). The exercise intensity can be also expressed in
Metabolic Equivalent of Task or METs, where 1 MET is 1 kcal of energy expenditure per
kg of body weight per hour. Normally, 1 MET is considered equivalent to 3.5ml of oxygen
consumption per kg of body weight per minute. In other words, the intensity of a particular
exercise in METs can be converted to different intensities in terms of %V O2max for different
individuals.
Muscles during aerobic exercises meet their energy via oxidation of glucose and fatty
acids [57], [50], [97]. The exercise intensity and the rate at which the person consumes
oxygen during the exercise determines the relative fraction of the substrates used to meet the
energy. About, 10% of the energy needs during aerobic exercise are met by oxidizing glucose
absorbed from the bloodstream via GLUT4/GLUT1 transporters [97]. The aerobic exercise
activates GLUT4 transporters to absorb glucose from the bloodstream, despite the insulin
levels during the aerobic exercise [89], [46], [112]. Low intensity (e.g. 25%V O2max) exercises
meet most of the remaining energy needs via oxidizing fatty acids [97]. In a moderate and
high intensity exercise, a significant fraction of energy needs is met by oxidation of glucose
derived from the glycogen stored locally in the exercising muscles. [97] reported that when
the intensity of the aerobic exercise is about 65%V O2max, 30% of the energy comes from
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the oxidation of glucose obtained from locally stored glycogen. Also, it is reported in [50]
that the oxidation of glucose that is absorbed from the bloodstream and obtained from
local stored glycogen provides for about 50% and almost 100% of the energy needs when the
exercise intensities were 50%V O2max and 100%V O2max respectively. Most of the remaining
energy needs are met by the oxidation of fatty acids [31]. A small quantity of the energy
needs is met by the glycolysis of glucose 6-phosphate derived from locally stored glycogen.
The glycolysis level increases linearly with exercise intensity. Finally, a very small fraction of
energy needs is acquired by consuming branched amino acids absorbed from the bloodstream
[31]. When the glycogen stored in the liver and the muscles is depleted, the individual will
not be able to perform high intensity exercises (almost impossible). On the other hand, in
the resting state the muscles meet 85–90% of their energy needs via the oxidation of fatty
acids. The remaining energy comes from the oxidation of glucose (about 10%) and amino
acids (1–2%).[57] [50] [110]. In addition, [59] reported that the absorbed glucose is used for
oxidation, glycogen synthesis, and glycolysis. The glucose oxidation and glycolysis processes
(in muscles) increase with the insulin level in the bloodstream during the resting conditions.
CarbMetSim uses Muscles class (object) to model skeletal muscles. The skeletal muscle
(in the simulator) responds to the resting condition and the aerobic exercise only. The current
version cannot simulate anaerobic exercises,and neither can it distinguish among different
muscle groups. At the start of the simulation, a method in HumanBody class calculates
the %V O2max associated with the individual being simulated using the tables in [58]. The
simulator uses the following parameter for the %V O2max estimation: individual’s gender,
age, and self-assessed fitness level within his/her age group. These individual’s parameters
are all entered to the simulator as configuration parameters. In CarbMetSim, the intensity
of exercise is translated from the units of METs into %V O2max. As stated before, the
energy needs (to do the exercise) is met via the oxidation of glucose derived from locally
65
stored glycogen. The initial amount of glycogen stored in the Muscles and the maximum
amount the simulator can hold are set via configurable parameters. By default, both these
parameters have values equivalent to 500 grams of glucose.
The Muscles object performs the following actions when the simulator (particulary Hu-
manBody class) is in the Fed_Exercising or PostAbsorptive_Exercising state during a tick:
1. Oxidation of glucose absorbed from the Blood: The Muscles absorb a random amount
of glucose from the Blood so that the absorbed glucose can be oxidized to meet on
average 10% of the energy needs during the tick as stated previously. The Muscles
absorb up to a configurable variable that is equal to 30µmol/kg/min (by default). The
absorption does not depend on the current insulinLevel in the Blood.
2. Oxidation of glucose derived from local glycogen: The Muscles absorb glucose derived
from local glycogen to meet a fraction of energy needs. The exercise intensity (in
%V O2max) is used (by oxidation) to determine this fraction value. As the exercise
intensity increases from 0 %V O2max to 100 %V O2max, a value between 0 and 0.9 is
chosen using a sigmoid function (currently, the compressed CDF of a normal distri-
bution), such that values close to 0.4 and 0.9 will be assigned for exercise intensities
50 %V O2maxx and 100 %V O2max, respectively. This value is then used as the mean
to generate a random value that gives the fraction of energy needs during the tick, as
long as a sufficient amount of local glycogen is available.
3. Glycolysis: Increases of exercise intensity yield to increases in the glycolysis flux. When
the exercise intensity increases from 0 %V O2max to 100 %V O2max during the tick,
the glycolysis flux increases linearly from a (poisson distributed) random value (with
glycolysisMin_ as the mean) to glycolysisMax_. The glycolysis process uses the glu-
cose 6-phosphate from the locally stored glycogen and adds the resulting lactate to the
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Blood object.
4. Fatty Acid Consumption: If the glycolysis and glucose oxidation processes do not
provide the current energy needs, Muscles will consume the fat from the AdiposeTissue
to meet the remaining energy needs.
The Muscles object performs the following actions when the simulator (HumanBody class)
is in Fed_Resting or PostAbsorptive_Resting state during a tick:
1. Glucose Absorption: GLUT4 is responsible of the basal glucose absorption [45] as
described previously. Moreover, basal absorption via GLUT1s happens at a configured
rate (by default zero).
2. Glycolysis: A fraction of the absorbed glucose is consumed via glycolysis and the
generated lactate is added to the Blood object as described in Section 3.4.
3. Glycogen Synthesis: Glycogen will be synthesized if the glycogen store of the Mus-
cles is less than the maximum amount that Muscles could hold [45]. The simulator
will generate a poisson distributed random amount of the absorbed glucose (with a
configurable mean, 7.0mg/kg/min by default), and it will be converted to glycogen.
4. Oxidation: The rest of the absorbed glucose is consumed via oxidation.
5. Fatty Acid Consumption: If glycolysis and glucose oxidation processes do not pro-
vide the energy needs during the resting state, Muscles will consume fat from the
AdiposeTissue to meet the remaining energy needs.
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4.9 Adipose Tissue
In CarbMetSim the AdiposeTissue object serves as the storage for fat. The Liver class
adds the exceeded glycogen in the form of fat (converted to fat) to the AdiposeTissue
object. Also, the Intestine object adds the fat contents in chyme to the AdiposeTis-
sue object. Fat in AdiposeTissue is consumed or removed by the Muscles to meet
its energy needs. These are the only operations are supported by CarbMetSim cur-
rently. Otherwise, CarbMetSim does not yet have a detailed implementation of lipid
metabolism.
4.10 Brain
The brain uses GLUT3 transporters to absorb glucose from the bloodstream, so the
brain cells can meet their energy needs by oxidizing glucose. The brain oxidizes about
120 g of glucose per day. In other words, the brain absorbs about 83.33 mg of glucose
per minute [37],[59]. In CarbMetSim, the brain operation is represented in the Brain
class, which consumes a poisson distributed random amount of glucose every minute
from the Blood object (with a mean 83.33 mg).
4.11 Heart
The heart uses both GLUT1 and GLUT4 transporters to absorb glucose from the
bloodstream. Consuming glucose and lactate provides up to 30% of the heart’s energy
needs [1]. However, the heart meets most of its energy needs by oxidizing fatty acids.
In CarbMetSim the Heart object absorbs a poisson distributed random amount of
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Validation of CarbMetSim for a meal event
This chapter demonstrates the ability of CarbMetSim to model carbohydrate metabolism
in normal people and type II diabetic patients in the post-absorptive and post-prandial
phases. The default values of various configurable parameters had to be determined for
normal subjects before the start of the simulation processes. Therefore, CarbMetSim is
configured to provide a close match with measurements reported in Woerle et al. [114]. In
their literature, Woerle et al. did in-depth study on determining the flux along different
pathways for glucose arrival and consumption after a standard meal. The particpants in the
study were type II diabetic patients and normal subjects. It included 26 subjects with type
II diabetes, and 15 age/weight/sex-matched normal subjects (without diabetes). Diabetic
subjects included 16 men and ten women with the following characteristics: age 53±2 years,
body weight 93±4 kg, BMI 30±1 kg/m2, body fat 34 ±3%, and average HbA1c 8.6 ± 0.3%.
The normal subjects included seven men and eight women with the following characteristics:
age 49 ± 3 years, body weight 89 ± 4 kg, body fat 36 ± 3 %, and BMI 30 ± 1 kg/m2. All
the participants (diabetic and normal) consumed a standard breakfast consisting of 84 g of
glucose, 10 g of fat and 26 g of protein, at 10am on the day of the measurements after a fast
of more than 14 hours. Measurements were carried out for the post-absorptive phase before
the breakfast. The post-prandial phase was assumed to be six hours in duration after the
breakfast.
We performed two sets of simulations using CarbMetSim: one for a normal subject and
one for a type II diabetic subject. In each set, 30 simulations with different seeds for a
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random number generation were performed. Most of the configurable simulation parameters
were set to their default values. Indeed, they were set so that the normal subject simula-
tions produced a close match with measurements reported in [114]. The insulin level in the
reported measurements did not appear to influence the gluconeogenesis flux; therefore, the
impact of the insulin level on the gluconeogenesis flux was disabled in CarbMetSim for the
reported results in this chapter. Table 5.1 shows the configurable parameters for which the
default values were not used. In the reported experiments the parameters did not change
in value with the body state. However, the simulator is able to use different values for the
parameteres based on the body state. Also, CarbMetSim sets the value of bodyWeight and
age_ to the average values reported for subjects in each category in [114]. As reported
earlier, the age_, gender_and fitnessLevel_ parameters are used to estimate %V O2max for
the person being simulated. However, they are not pertinent in the reported simulations in
this chapter.
The following parameters (see Tables 5.2 and 5.3) were set as per the data reported in
[114]:
1. The baseGlucoseLevel_ and highGlucoseLevel_ values were set according to the re-
ported values for the fasting and the peak BGL [114].
2. The peakInsulinLevel_ values were set to the reported peak plasma insulin levels [114].
3. The average glycogen breakdown flux in the Liver (glycogenToGlucoseInLiver_) val-
ues was set to obtain a good match with the reported values for the post-absorptive
glycogen breakdown flux and the total glycogen breakdown in the liver during the
post-prandial phase.
The length of each simulation run was 18 hours of simulated time. It started at 12 am and
ended at 6 pm the next evening, with one breakfast meal intake that occurred at 10 am. The
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meal consisted of 84 g of glucose, 10 g of fat, and 26 g of protein. During the simulated time,
there were no other events. Also, at the beginning of the simulation (when the simulation
started at 12 am) the simulated subject was in the post-absorptive phase.
Normal Type II Diabetic
age_ (years) 49 53
gender_ 0 (male) 0 (male)
fitnessLevel_ (%ile) 50 50
bodyWeight (kg) 89 93
minGlucoseLevel_ (mg/dl) 50 50
baseGlucoseLevel_ (mg/dl) 90 210







glucoseToGlycogenInLiver_ (mg/kg/min) 4.5 6.75
glycogenToGlucoseInLiver_ (mg/kg/min) 0.9 1.25
gngLiver_ (mg/kg/min) 0.16 0.38
gngKidneys_ (mg/kg/min) 0.16 0.38
Table 5.1: Configuration parameters for simulations for a single meal
event.
Following Figures shows the related results in simulating a normal subject and a diabetic
subject. The Figures displays the minute-by-minute values of interest in the two simulations
with a particular seed value. In the details, Figure 5.1 shows that the gastric emptying has
been completed within 45 minutes of meal intake. Some of the delay in gastric emptying
(shown in Figure 5.1) was caused by the fat contents of the meal. Figure 5.2 displays
the quick digestion of glucose when it arrives in the Intestine. Also, Figure 5.3 shows the
appearance of consumed glucose in the PortalVein as described previously. Figure 5.4 shows
the changes in BGL during the post-prandial phase which starts from the post-absorptive
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Woerle et al. [114] Simulations
Before Breakfast
BGL 4.7± 0.1 mM (84.6± 1.8 mg/dl) 91.937± 0.010 mg/dl
Glycogen Breakdown 5.5± 0.6µmol/kg/min (88.1± 9.6 mg/min) 80.064± 0.171 mg/min
Gluconeogenesis 2.6± 0.2µmol/kg/min (41.6± 3.2 mg/min) 41.720± 0.053 mg/min
90 Minutes After Breakfast
Plasma Insulin 290± 29 pM 0.993± 0.001
Glycogen Breakdown 1.3± 0.6µmol/kg/min (20.8± 9.6 mg/min) 0 mg/min
Gluconeogenesis 2.6± 0.2µmol/kg/min (41.6± 3.2 mg/min) 41.824± 0.051 mg/min
Peak Post-prandial BGL 8 mM (144 mg/dl) 144.826± 0.046 mg/dl
Total Glucose Consumed/Produced During 6 Hours After The Breakfast
Gluconeogenesis 15.3± 1.2 g 15.041± 0.001 g
Glycogen Breakdown 4.3± 1.7 g 16.241± 0.002 g
Glucose Excretion in Urine 0.7± 0.4 g 0 g
Oxidation 45.6± 2.6 g 47.055± 0.008 g
Glycolysis 21.5± 2.2 g 22.614± 0.002 g
Glycogen Storage 40.6± 3.6 g 45.616± 0.008 g
Table 5.2: Normal Subjects: Key Measurements From Woerle Et Al.
[114] and Corresponding Results From 30 Simulations with Differ-
ent Seeds. ”Before Breakfast” Simulation Results Were Observed at
9.59AM. All Values Expressed as Mean ± Std Error.
levels before 10 am.
Post-Absorptive Phase: Figure 5.5 shows that insulinLevel during the post-absorptive
phase is low enough to ensure that the glycogen breakdown in the Liver occurs at the peak
level as shown in Figure 5.7. Figure 5.6 shows that there is no glycogen synthesis in the
Liver during this phase. Figure 5.10 and Figure 5.9 show that glucose consumption via
oxidation and glycolysis in various organs are at their minimum levels. Also, during this
phase, Gluconeogenesis happens in the Liver and the Kidneys (as shown in Figure 5.8)
which is unaffected by the insulinLevel as reported in [114]. Also, Gluconeogenesis happens
at the configured rates specified in [114] and provides the second source of glucose during
the phase. Since the minimum glucose oxidation flux is mostly specified by the needs of the
Brain and Heart, the configured values for the minimum glycolysis flux are selected to ensure
that the total glucose consumption matches the total glucose production during this phase.
Hence, the glycolysisMinImpact_ parameter was set to 4.0 in simulations for the type II
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Woerle et al. [114] Simulations
Before Breakfast
BGL 11.7± 0.6 mM (210.6± 10.8 mg/dl) 219.820± 0.063 mg/dl
Glycogen Breakdown 7.0± 0.4µmol/kg/min (117.2± 6.7 mg/min) 116.089± 0.183 mg/min
Gluconeogenesis 3.8± 0.3µmol/kg/min (63.6± 5 mg/min) 64.092± 0.078 mg/min
90 Minutes After Breakfast
Plasma Insulin 179± 19 pM 0.6± 0.000
Glycogen Breakdown 3.8± 0.7µmol/kg/min (63.6± 11.7 mg/min) 0 mg/min
Gluconeogenesis 3.8± 0.3µmol/kg/min (63.6± 5 mg/min) 64.127± 0.084 mg/min
Peak Post-prandial BGL 20 mM (360 mg/dl) 363.064± 0.076 mg/dl
Total Glucose Consumed/Produced During 6 Hours After The Breakfast
Gluconeogenesis 26.9± 2.2 g 23.069± 0.001 g
Glycogen Breakdown 10.1± 1.2 g 22.648± 0.006 g
Glucose Excretion in Urine 17.4± 2.7 g 16.750± 0.007 g
Oxidation 32.8± 2.8 g 35.039± 0.001 g
Glycolysis 28.7± 2.2 g 31.386± 0.010 g
Glycogen Storage 46.3± 3.3 g 46.514± 0.007 g
Table 5.3: Subjects with Type II Diabetes: Key Measurements From
Woerle Et Al. [114] and Corresponding Results From 30 Simulations
with Different Seeds. ”Before Breakfast” Simulation Results Were
Observed at 9.59AM. All Values Expressed as Mean ± Std Error.
diabetic subject to ensure that glycolysis flux for the type II diabetic subject during the post-
absorptive phase is much higher than that for the normal subject, as shown in Figure 5.9. In
other words, the total glucose production from the glycogen breakdown and gluconeogenesis
processes is matched by the total glucose consumption from the oxidation, glycolysis, and
excretion in urine in the post-absorptive phase. This makes the BGL stabilize at a value
near the baseGlucoseLevel_. Any temporary mismatch between glucose production and
consumption is quickly fixed, because the glycogen breakdown in the Liver is configured to
quickly slow down with increase in the insulinLevel.
Post-Prandial Phase: The following paragraphs illustrate the simulation results during
the post-prandial phase that begins with food intake at 10:00 am. Figure 5.4 shows that BGL
begin to rise when the consumed glucose just arrives in the PortalVein. Also, Figure 5.5 shows
that insulinLevel increases due to an increase in the BGL. The increase of the insulinLevel
halts the glycogen breakdown in the Liver as shown in Figure 5.7 The influx of consumed
glucose is more than enough to compensate for the halt in glycogen breakdown. Indeed,
74
Figure 5.1: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Gastric Emptying
(mg/minute) in simulations with a particular seed for random num-
ber generation.
the process of digesting glucose provides approximately 700 mg/minute at peak, while the
glycogen breakdown provides approximately 120 and 80 mg/minute for type II diabetic and
normal subjects respectively. Figure 5.8 shows that glucose production via gluconeogenesis
continues as before, unaffected by the increase in the insulinLevel as reported in [114].
Figure 5.12 shows that GLUT4 activation for the normal subject increases proportionally
in response to the increase in the insulinLevel, and therefore an increase in the glucose
absorption by Muscles. The glycogen storage in the Muscles are full, and therefore, the
absorbed glucose cannot be added as glycogen in the Muscle cells. Figure 5.10 shows that
the increased oxidation flux in the normal subject between 10 am and 1 pm is a result of
the increase in the glucose oxidation in the Muscles. On the other hand, the Muscles in
the diabetic subject are not able to absorb glucose at the normal rate as in the normal
subject case (Figure 12). This caused by setting the glut4Impact_ parameter to 0.25, which
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Figure 5.2: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Carbohydrate Di-
gestion in Intestine (mg/min) in simulations with a particular
seed for random number generation.
indicates an impaired in GLUT4 activation for a type II diabetic patient. Also, most of
the glucose absorbed in the diabetic subject case is consumed via glycolysis because the
glycolysisMinImpact_ parameter was set to 4.0, comparing to 1.0 for the normal subject.
This explains why the oxidation flux shown in Figure 10 does not show any rise in the post-
prandial phase for the type II diabetic subject. CarbMetSim sets glycolysisMaxImpact_
to 1.25 for the type II diabetic subject, so the peak glycolysis flux for the type II diabetic
subject will be higher than that for the normal subject to achieve a close match with reported
results in [114] for the total glycolysis flux during the post-prandial phase between 10 am
and 4 pm (see Table 5.3). Also, note that the glycolysis flux has been increased in other
organs due to an increase in the insulinLevel as it is shown in Figure 5.9. Figure 5.6 shows
that when the BGL approaches the highGlucoseLevel_, the glycogen synthesis process in
the Liver starts and rapidly ramps up to its peak level, and thereby significantly slows down
76
Figure 5.3: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Appearance of Di-
gested Glucose in PortalVein (mg/min) in simulations with a
particular seed for random number generation.
any further increase in BGL. As reported in [114], and shown in Table 5.2 and 5.3, the
glycogen storage during the post-prandial phase is higher for the type II diabetic subject
than for the normal subjects, even though the peak insulin levels for the type II diabetic
subject is smaller than for a normal subject. The insulinLevel has a significant impact on
glycogen synthesis in the Liver, as discussed previously. In order to compensate for lower
insulin levels in the type II diabetic subjects, the glucoseToGlycogenInLiver_ parameter in
the simulations is assigned a value equal 6.75 mg/kg/min, which is higher than the value
assigned for glucoseToGlycogenInLiver_ parameter for normal subjects (4.5 mg/kg/min).
The type II diabetic patient lose a significant amount of glucose via excretion in urine
(see Figure 5.11). This makes BGL remain around the highGlucoseLevel_ as long as the
digested glucose is appearing in the PortalVein at the peak rate. When the digested glucose
occurrence in the PortalVein slows down, the BGL begins to drop and the glycogen synthesis
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Figure 5.4: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Blood Glucose Level
(mg/dl) in simulations with a particular seed for random number
generation.
in the Liver rapidly comes to a halt. Therefore, this process slows down the rate at which
the BGL falls. When the BGL decreases, the glycolysis flux, the glucose absorption by the
Muscles, and the glucose excretion in the urine decrease consequently. This slows down the
rate of the BGL decreases. When BGL approaches the baseGlucoseLevel_, the glycogen
breakdown in the Liver quickly increases to prevent any more decreases in the BGL, and
another post-absorptive phase begins.
Comparison with Measurements from Woerle et al.[114]: A comparison between
the reported measurements in [114] and the results obtained from the simulations are dis-
cussed in the following paragraphs. Tables 5.2 and 5.3 show the significant measurements
from [114] for normal and type II diabetes subjects, respectively, along with the correspond-
ing results from the simulations. In the simulations, CabrmetSim were configured to use the
peak glycogen breakdown and gluconeogenesis flux values during the post-absorptive phase
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Figure 5.5: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Insulin Level in sim-
ulations with a particular seed for random number generation.
that are reported in [114]. By using the appropriate values for other configurable parameters
(shown in Table 5.1), the post-absorptive BGL values in the simulations were near the values
reported in [114] for both normal and type II diabetic subjects. To ensure that the insulin-
Level does not have any impact on gluconeogenesis flux, as stated previously, the simulations
were configured appropriately. In consequence, the gluconeogenesis flux in simulations 90
minutes after breakfast was the same as the ones before the breakfast, which matches the
results reported in [114]. The glycogen breakdown 90 minutes after the breakfast was con-
siderable in [114] but had completely halted in the simulations. Generally, the peak BGL
during the post-prandial in simulations matched the reported results in [114]. The glucose
produced and consumed through various pathways in the simulations for the normal subject
during 6 hours after the breakfast matched the values reported in [114]. However, the glyco-
gen breakdown case was an exception in the simulation results. It is clear from the Figures
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Figure 5.6: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Liver Glycogen Syn-
thesis in simulations with a particular seed for random number gen-
eration.
that the post-prandial phase in simulations was over by 1 pm, which make the glycogen
breakdown occurred at the peak level between 1 pm and 4 pm (See Figure 5.7). In [114], the
case was different and the average glycogen breakdown flux for 6 hours after the breakfast
was low. Also, the glycogen breakdown was still considerable 90 minutes after the breakfast
when the insulin levels were at their peak. It can be reasoned that the glycogen breakdown
is relatively slow in responding to the insulin levels impact. A similar mismatch in the total
glycogen breakdown during 6 hours after the breakfast was observed between the simulation
results and the reported values in [114] for the type II diabetic subject. Moreover, Woerle et
al. reported higher total gluconeogenesis flux for the 6 hours after the breakfast (26.9±2.2 g)
for the type II diabetic patient than what was observed in the simulations (23.069±0.001 g).
The increased gluconeogenesis flux in [114] during the post-prandial phase may be attributed
to the higher availability of gluconeogenesis substrates. However, the gluconeogenesis flux
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Figure 5.7: Simulating a meal event for a normal and a subject
with type II Diabetes: Minute-by-minute values of Liver Glyco-
gen Breakdown in simulations with a particular seed for random
number generation.
in the simulation had the same values during both the post-prandial and post-absorptive
phases. CarbmetSim does not support increase in gluconeogenesis flux due to the increased
availability of substrates. The other results for type II diabetic subjects were close to the
results reported in [114]. Generally, it can be said that the simulation results closely matched
the results reported in [114] for both normal and type II diabetic subjects.
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Figure 5.8: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Total Gluconeogen-
esis in Liver and Kidneys in simulations with a particular seed for
random number generation.
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Figure 5.9: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Total Glycolysis in
All Organs in simulations with a particular seed for random number
generation.
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Figure 5.10: Simulating a meal event for a normal and a subject
with type II Diabetes: Minute-by-minute values of Total Glucose
Oxidation in All Organs in Liver and Kidneys in simulations with
a particular seed for random number generation.
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Figure 5.11: Simulating a meal event for a normal and a subject with
type II Diabetes: Minute-by-minute values of Glucose Excretion
in Urine in All Organs in Liver and Kidneys in simulations with a
particular seed for random number generation.
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Figure 5.12: Simulating a meal event for a normal and a subject with
Type II Diabetes: Minute-by-minute values of Glucose Absorption




Validation of CarbMetSim for an exercise event
Glucose is the main energy source utilized by muscles during moderate to high-intensity
exercise. The exercise muscles absorb glucose from the bloodstream and break down the
local stored glycogen to provide the energy needs during an exercise. Indeed, the muscles do
not depend on the insulin level to get the absorbed glucose, because the exercise is sufficient
to activate GLUT4 transporters [89][46][112]. As reported previously, glucose oxidation
plays a signiifcant role in meeting energy needs during physical exercise. The metabolism
of Carbohydrates during and after a physical exercise has been analyzed widely for normal
and diabetic subjects in [112][50][81][16][66][67].
The physical exercise in a normal subject case induces the secretion of glucogon [4] [39]
[115] [60] and inhibits the secretion of insulin [110][102][111][39][115]. As consequence, the
liver will produce more glucose to meet the needs of the energy requirements by breaking
down glycogen into glucose. The glycogenolysis (the process that breaks glycogen into glucose
in the liver and the exercising muscles) and the gluconeogenesis (described previously) are
the two processes that produce glucose as long as the glycogen is available in the liver and in
the exercising muscles. The glucose production from these two processes generally matches
the total glucose consumption by exercising muscles ,which makes the BGL remain at the
normal level [112][50]. When the glycogen stores are used up, the BGL will drop, because
the produced glucose from the gluconeogenesis process alone is not adequate to match the
glucose consumption by the exercising muscles. On the other hand, the insulin level in the
diabetic patients (type I and type II) is not affected (and therefore not reduced) by the
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physical exercises. In consequence, the glycogen breakdown in the liver will not be sufficient
to produce the additional glucose needs [118], and the BGL will drop remarkably during
exercises. However, BGL in the type I diabetic case may increase during an exercise (which
was high before the exercise). This happens due to an increase in glucose production via
the glycogen breakdown in the liver (due to secretion of glucagon and other hormones).
This increase of BGL is much higher than the impaired rate at which the exercising muscles
absorb glucose in some type I Diabetic patients [112] [9] [61][50].
In CarbMetSim, we are able to simulate the impact of aerobic physical exercise. This
chapter reports the results of simulations where normal male subjects perform a long aerobic
exercise following an overnight fast. These simulations replicate the experiments reported
in [3] and [5]. In [3], twenty normal male subjects were observed when they performed a
leg exercise at intensity 58%V O2max for 3 to 3.5 hours after a 12 to 14 hour overnight
fast. Also, in [5] study, twelve normal male subjects participated. The subjects performed a
leg/arm exercise at intensity 30%V O2max for 2 hours after a 12 to 14 hour overnight fast.
Table 6.1 shows the characteristics of these subjects. For each subject, the concentrations of
glucose and other hormones in the blood were recorded. Table 6.2 and Figure 6.1 show the
relevant BGL data reported in [3] and [5]. In this chapter, we explain each set of BGL data
and show that CarbMetSim with proper configuration can replicate each pattern.
6.1 Exercise at intensity 58% VO2max
This section discusses the experiments that replicate the physical exercise at intensity
58%V O2max that is reported in [3]. As seen in Table 6.2 and Figure 6.1, the BGL drops
continuously as the exercise progresses, and it reaches the hypoglycemic levels towards the
end of the exercise. However, a modest recovery from this hypoglycemic level happens when
the exercise concludes. The results indicate that the liver glycogen was drained some time
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after the start of the exercise and the only sources of glucose for the exercising muscles were
the local glycogen and the gluconeogenesis. This can be explained due to the fact that the
exercise began after a long fast and the drops in BGL. Also, the Figure and the table show
that the BGL dropped continuously because the gluconeogenesis process alone was not able
to compensate for the glucose absorption by the exercising muscles from the bloodstream.
Even after the exercise finished, the gluconeogenesis was the only source of glucose, and it
was not adequate to bring the BGL back to pre-exercise level.
Average Standard Error Range
20 Subjects Doing Leg Exercise at 58%V O2max [3]
Age (years) 26 0.7 20-31
Weight(Kg) 71 1.6 57-82
Height(cm) 182 1.4 169-187
V O2max(liters/min) 3.8 .13 2.6-4.8
6 Subjects Doing Arm Exercise at 30%V O2max [5]
Age (years) 27 1 24-29
Weight(Kg) 80 6 61-100
Height(cm) 186 4 171-198
V O2max(liters/min) 4.1 .3 3.3-4.8
6 Subjects Doing Leg Exercise at 30%V O2max [5]
Age (years) 27 2 19-31
Weight(Kg) 74 4 62-93
Height(cm) 181 3 170-194
V O2max(liters/min) 3.9 .2 3.3-4.8
Table 6.1: Characteristics of Subjects Reported in [3] and [5].
Blood Glucose Level (mmol/l): Average ± Standard Error
Leg Exercise at 58%V O2max [3] Arm Exercise at 30%V O2max [5] Leg Exercise at 30%V O2max [5]
Rest 4.39±0.08 4.00±0.11 4.33±0.09
Exercise:40min 4.09±0.10 4.01±0.31 4.28±0.10
Exercise:90min 3.86±0.28 4.06±0.20 4.07±0.16
Exercise:120min 3.55±0.11 3.98±0.23 3.81±0.15
Exercise:180min 2.78±0.13
Exercise:210min 2.56±0.13
Recovery:10min 3.12±0.13 3.96±0.31 4.06±0.25
Recovery:20min 3.19±0.13 3.76±0.29 4.11±0.25
Recovery:40min 3.18±0.10 3.83±0.25 4.13±0.21
Table 6.2: BGL Measurements Reported in [3] and [5].
To simulate the described experiment, we created twenty pairs of age and weight values
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for normal subjects using the average and standard error values specified in [3] (also reported
in Table 6.1). Each simulation was begun at the simulated time of 12 am. and we simulated
a subject to do a 210-minutes long exercise at intensity 58%V O2max starting at 12 pm.
Each simulation finished at the simulated time of 5 pm and used the same seed value for the
random number generation. To match the reported BGL in [3], the simulation parameters
were configured to make the liver glycogen exhaustion early on in the exercise. Therefore,
it matches the reported BGL. Table 6.3 shows the simulation parameters for the simulated
subjects. For each simulation, the initial glycogen store in the Liver was configured to 60 g;
this means that a little glycogen was left in the Liver by the time the exercise event started
(at 12 pm). Also, to limit the glucose production via gluconeogenesis during the exercise,
the gngImpact_ parameter was set to values between 13.2 and 15.5.
The results of simulating the exercise event at intensity 58%V O2max using CarbMetSim
is shown in Figure 6.2, Figure 6.3, Figure 6.4, and Figure 6.5. In the details, Figure 6.2 shows
the BGL values for each simulated subject along with the average BGL values reported in [3].
As is clear from the figure, the BGL values in the simulations are close to the measurements
reported in [3]. Also, the BGL at the beginning of the exercise were hovaring around its
pre-exercise levels, and then it dropped continuously as the exercise progresses. It reached
the hypoglycemic levels at the end of the exercise. However, a modest recovery from the
hypoglycemic level happened after the exercise finished(did not reach the pre-exercise level
though). Figure 6.3 shows the amount of glycogen left in the Liver for a simulated subject.
The initial amount of glycogen in the Liver was configured in a manner that ensures that
the glycogen amount will deplete in the early stages of the physical exercise. Therefore, all
the glycogen in the Liver was depleted by 1 pm, after which the gluconeogenesis was the
only source of glucose for this subject. The glycogen breakdown flux in the Liver and the
combined gluconeogenesis flux in the Liver and Kidneys are shown in Figure 6.4 and 6.5
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Figure 6.1: Average BGL Measurements (After Conversion to mg/dl)
Reported in [3] and [5].
for the same subject. Both Figures show that the glycogen breakdown flux and the gluco-
neogenesis flux fluctuated between high and low values when the exercise began and before
the Liver glycogen was depleted. This behavior is in agreement with our previously dis-
cussed findings on how the insulinLevel varies, as well as how the glycogen breakdown in the
Liver and gluconeogenesis in the Liver and Kidneys react to the insulinLevel. Previously,
we have stated that when the BGL drops below the baseGlucoseLevel_, the insulinLevel
will be set to 0 when the simulated subject is engaged in an exercise at an intensity that is
higher than the intensityPeakGlucoseProd_ (default value 20% VO2max). In the current
simulation experiment, the exercise intensity was 58%V O2max and it is higher than the in-
tensityPeakGlucoseProd_ parameter. Therefore, the insulinLevel dropped to zero when the
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BGL dropped below the baseGlucoseLevel_. This pushes the glycogen breakdown process
in the Liver and gluconeogenesis process in the Liver and Kidneys to produce glucose at the
highest rates. However, when the BGL exceeded the baseGlucoseLevel_, the insulinLevel
exceeded the baseInsulinLevel_ and, therefore the glycogen breakdown and gluconeogenesis
fluxes fell down to the normal levels. After the liver glycogen was totally consumed, the glu-
coneogenesis process was not able to raise BGL above the baseGlucoseLevel_, even though
it occurs at the highest rate. This explains why the insulinLevel stayed at the zero level for
the rest of the exercise duration, and the gluconeogenesis process was the only source of glu-
cose for the blood. When the exercise finished, the insulinLevel increased to a positive value
below baseInsulinLevel_, and in response the gluconeogenesis flux assigned a value between
the regular and the highest levels. In other words, the gluconeogenesis process at this time
allowed the BGL to rise from the hypoglycemic level to a level below the baseGlucoseLevel_.
Subject # 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
age_ (years) 23 26 26 30 22 25 26 24 24 22 20 23 31 26 26 30 21 29 25 26
gender_ (0=Male) 0
fitnessLevel_ (%ile) 50






gngImpact_ 15.5 15.1 15.35 13.2 15.35 14.75 14.5 14.5 14.7 15.1 14.55 14.3 13.5 15.25 15.1 13.5 14.35 15 15 14.6
Initial Liver Glycogen (g) 60.0
Table 6.3: Configuration parameters for simulations for a single ex-
ercise event at intensity 58 %V O2max.
6.2 Arm exercise at intensity 30%V O2max
This section discusses the experiments that replicate the arm exercise at intensity 30
%V O2max that is reported in [5]. In these simulations, the BGL maintain its pre-exercise
level through the duration of the exercise, as shown in Figure 6.1 and Table 6.2. Also, it
is shown that there is a small drop that occurred during the recovery phase. Analyzing the
results in the table and the figure indicate that the liver glycogen did not exhaust during
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Figure 6.2: BGL results of simulations replicating a physical exercise
event at intensity 58 %V O2max as reported in [3]. Green: BGL for
20 simulated subjects; Red: average BGL reported in [3]
the exercise period and that both processes (liver glycogen breakdown and gluconeogenesis)
were able to meet the glucose needs of the exercising muscles. Moreover, both processes
returned to their pre-exercise levels after the exercise finished, and in consequence the BGL
got back to its pre-exercise level.
CarbMetSim does not differentiate between various types of muscles. Indeed, the arm
exercise was considered in the reported simulations as a regular exercise. To simulate the arm
exercise experiments, we generated 6 age and weight value pairs for normal male subjects
using the average and standard error values specified in [5] (reported in Table 6.1 as well).
Each simulation begun at the simulated time 12 am and simulated a subject to do a 120-
minutes long exercise at intensity 30%V O2max starting at 12 pm. Each simulation finished
at the simulated time 5 pm and used the same seed value for the random number generation.
Table 6.4 shows the simulation parameters for the simulated subjects, which is different from
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Figure 6.3: Liver glycogen for the subject # 1: results of simulations
replicating a physical exercise event at intensity 58 %V O2max as
reported in [3]
the default values. For each simulation, the initial glycogen store in the Liver was configured
to 100 grams to ensure that the liver glycogen does not get exhausted during the exercise.
Also, to guarantee that the glucose produced from the gluconeogenesis process will rise to a
high enough level when required during the exercise, the gngImpact_ parameter was set to
value 15.0.
The results of simulating the arm exercise event at intensity 30%V O2max using Carb-
MetSim is shown in Figure 6.6, Figure 6.7, Figure 6.8, and Figure 6.9. Specifically, Figure
6.6 shows BGL values for each simulated subject along with the average BGL values reported
in [3]. The values in the figure indicate that the simulator was able to generate BGL values
for the simulated subjects that are very close to the measurements reported in [3]. Indeed,
the BGL values for all the simulated subjects were hovering around its pre-exercise level
during the exercise time and then returned to the pre-exercise level. The results show that
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Figure 6.4: Liver glycogen breakdown for the subject # 1: results
of simulations replicating a physical exercise event at intensity 58
%V O2max as reported in [3]
the liver glycogen did not deplete during the exercise and in the recovery phase as it is clear
in Figure 6.7, which shows the amount of glycogen left in the Liver for a simulated subject.
The glycogen breakdown flux in the Liver and the combined gluconeogenesis flux in the Liver
and Kidneys for the particular subject are shown in Figure 6.8 and Figure 6.9 respectively.
The figures show that the glycogen breakdown flux and the gluconeogenesis flux oscillated
between high and low values when the exercise started, exactly similar to the corresponding
simulations result for the 58%V O2max exercise (Section 6.1). The fluctuations happened for
the same reasons mentioned in section 6.1, and they explain the reasons of BGL oscillating
during the exercise duration. When the exercise concluded, the insulinLevel increased to the
baseInsulinLevel_ (as explained in Section 3.2) and in response the liver glycogen breakdown
and gluconeogenesis fluxes (and also the BGL) reached their pre-exercise levels.
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Figure 6.5: Total gluconeogenesis in Liver and Kidneys for the subject
# 1: results of simulations replicating a physical exercise event at
intensity 58 %V O2max as reported in [3]
6.3 Leg exercise at intensity 30 %V O2max
The leg exercise at intensity 30%V O2max experiments are discussed in this section.
Using Table 6.2 and Figure 6.1, the reader will realize that the BGL dropped modestly
during the exercise and then seemed to returned back to the pre-exercise level. Moreover,
the liver glycogen was not depleted during the exercise or in the recovery phase as the post-
exercise BGL approached the pre-exercise level. The modest drop of BGL throughout the
exercise indicates that the leg exercise was not able to stimulate both the liver glycogen
breakdown and gluconeogenesis processes to produce enough glucose to match the demands
of the exercising muscles. In other words, the total glucose production during exercise was
a little less than the amount absorbed from the blood by the exercising muscles.
As mentioned before, CarbMetSim does not differentiate between various types of mus-
cles, and hence the leg exercise was considered in the reported simulations as a regular
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Subject # 1 2 3 4 5 6
age_ (years) 24 29 28 27 27 28
gender_ (0=Male) 0
fitnessLevel_ (%ile) 50







Initial Liver Glycogen (g) 100.0
Table 6.4: Configuration parameters for simulations for a single "arm"
exercise event at intensity 30%V O2max.
exercise. To simulate the leg exercise experiments, we generated 6 age and weight value
pairs for normal male subjects using the average and standard error values specified in [5]
(reported in Table 6.1 as well). Each simulation begun at the simulated time of 12 am and
simulated a subject to do a 120-minutes long exercise at intensity 30%V O2max starting
at 12 pm. Each simulation finished at simulated time 5 pm and used the same seed value
for the random number generation. In this experiment, the goal was to control the glucose
production precisely via liver glycogen breakdown and gluconeogenesis during the exercise
to ensure that the total glucose production during the exercise was just a little less than
what the exercising muscles would absorb from the blood. Therefore, the liverGlycogen-
BreakdownImpact_ that controls the liver glycogen breakdown during exercise was reduced
to value 1.0, to limit extra glycogen breakdown in the Liver during the exercise. Also, the
glycogenToGlucoseInLiver_ parameter was increased appropriately (this variable controls
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Figure 6.6: BGL results of simulations replicating a physical exer-
cise event involving arms at intensity 30%V O2max as reported in
[5].Green: BGL for 6 simulated subjects; Red: average BGL reported
in [5]
the regular glycogen breakdown in the Liver).
Similarly, the parameter that controls the gluconeogenesis flux during the exercise gngIm-
pact_ was set properly to restrict glucose production via gluconeogenesis during the exercise.
Table 6.5 shows all simulation parameters for the simulated subjects, which is different than
the default values. For each simulation, the initial glycogen store in the Liver was configured
to 100 grams to ensure that the liver glycogen would not be depleted during the exercise or
the recovery phase. The results of simulating the leg exercise event at intensity 30%V O2max
using CarbMetSim is shown in Figure 6.10, Figure 6.11, Figure 6.12, and Figure 6.13. In
detail, Figure 6.10 shows BGL values for each simulated subject along with the average BGL
values reported in [3]. The values in the figure indicate that the simulator was able to gener-
ate BGL values for the simulated subjects that reasonably match the measurements reported
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Figure 6.7: Liver glycogen for the subject # 1: results of simulations
replicating a physical exercise event involving arms at intensity 30
%V O2max as reported in [5]
in [5]. The BGL for all the simulated subjects dropped modestly during the exercise dura-
tion and then returned to the pre-exercise level. Figure 6.11 shows the amount of glycogen
left in the Liver for a simulated subject. The glycogen breakdown flux in the Liver and the
combined gluconeogenesis flux in the Liver and Kidneys for the particular subject are shown
in Figure 6.12 and Figure 6.13 respectively. In Figure 6.12 it is clear that the liver glycogen
flux did not increase during the exercise . Also, in Figure 6.13 the reader will notice that
the gluconeogenesis happened at its highest level during the exercise time. This happened
because the BGL was below the baseGlucoseLevel_ during the exercise time and the exer-
cise intensity was greater than intensityPeakGlucoseProd_. Accordingly, the insulinLevel
was set to 0 throughout the exercise time, and this made the gluconeogenesis take place at
its highest level. Also, the insulinLevel was not able to stimulate liver glycogen breakdown
because liverGlycogenBreakdownImpact_ was set to value 1. The BGL dropped modestly
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Figure 6.8: Liver glycogen breakdown for the subject # 1: results
of simulations replicating a physical exercise event involving arms at
intensity 30 %V O2max as reported in [5]
during the exercise time (as desired) because the combined glucose production from the glu-
coneogenesis and liver glycogen breakdown processes was below the glucose absorbed from
the blood by the exercising muscles. When the exercise finished, the insulinLevel increased
to the baseInsulinLevel_ and consequently the gluconeogenesis flux and the BGL achieved
their pre-exercise level.
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Figure 6.9: Total gluconeogenesis in Liver and Kidneys for the sub-
ject # 1: results of simulations replicating a physical exercise event
involving arms at intensity 30 %V O2max as reported in [5]
Subject # 1 2 3 4 5 6
age_ (years) 20 31 22 29 30 25
gender_ (0=Male) 0
fitnessLevel_ (%ile) 50






gngImpact_ 6.2 5.6 6.2 6.2 5.6 6.1
Initial Liver Glycogen (g) 100.0
glycogenToGlucoseInLiver_(mg/kg/min) 1.4 0.9 1.3 1.25 1.05 1.25
liverGlycogenBreakdownImpact_ 1.0
Table 6.5: Configuration parameters for simulations for a single "leg"
exercise event at intensity 30%V O2max.
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Figure 6.10: BGL results of simulations replicating a physical exercise
event involving legs at intensity 30%V O2max as reported in [5].Green:
BGL for 6 simulated subjects; Red: average BGL reported in [5]
Figure 6.11: Liver glycogen for the subject # 1: results of simulations
replicating a physical exercise event involving legs at intensity 30
%V O2max as reported in [5]
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Figure 6.12: Liver glycogen breakdown for the subject # 1: results
of simulations replicating a physical exercise event involving legs at
intensity 30%V O2max as reported in [5]
Figure 6.13: Total gluconeogenesis in Liver and Kidneys for the sub-
ject # 1: results of simulations replicating a physical exercise event
involving legs at intensity 30%V O2max as reported in [5]
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Chapter 7
Conclusion and Future Work
CarbMetSim is an open-source discrete event simulator that models carbohydrate metabolism
in human beings. Also, it predicts minute by minute the BGL of the user in response to an
arbitrary length sequence of food and exercise activities. The simulator is implemented in
an object-oriented paradigm, where the key organs are represented as classes in the Carb-
MetSim. Other simulation tools exist, but they are classified as continuous time models
that use differential and algebraic equations to describe the physiological details. It can
be argued that it is much easier to revise and modify behavior described in software than
differential equations. Moreover, the other simulators are designed to predict the impact of
individual meals and are not available in a manner that can be freely used by individuals.
The key aspects of CarbMetSim’s design is covered in Chapter 3, while Chapter 4 covered
the implementation and the operation of the different organs of the simulator. The sim-
ulator implements the following key organs: stomach, intestine, portal vein, liver, kidney,
muscles, adipose tissue, brain and heart. The organs have been implemented to the extent
necessary to simulate their impact on the production and consumption of glucose. Chapter
5 and Chapter 6 present a validation of CarbMetSim’s behavior in response to single meal
and exercise events, where the simulator’s results were compared against the group-level
averages reported in the published research. However, important additional validation is
required before the simulator is considered ready to be used in diabetes self-management
applications and\or for research. For instance, it is required to have a validation against the
continuous blood glucose data of individuals representing various races, ages, and genders.
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Also, a validation against continuous blood glucose data of individuals representing different
forms and levels of diabetes and different lifestyles is needed.
Our future work on CarbMetSim will include more validation for the CarbMetSim’s be-
havior and provide functionalities that enhance the current limitations specified in chapter 1.
Also, CarbMetSim can be used in predicting HbA1c. This marker is considered the golden
indicator of average glycemic control. It measures the BGL periodically and evaluates the
impact of treatments on the individual’s BGL in the past three to four months.CarbMetSim
can be used to build a tool that can suggest user-specific real-time recommendations on diet
and exercise routines. These recommendations, if followed over the remainder of the day,
will allow the patient to achieve the target glycemic control regardless of the user’s current
BGL. Another future area of work is to model the fat metabolism to be utilized in predicting
changes in body weight in response to a diet and exercise activities.
Finally, we are aiming forward to reaching a stage where the CarbMetSim simulator can
be very a useful underlying platform for a number of diabetes self-management tools and a
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